Acute laryngitis and tracheitis

J10_LARYNGITIS

tracheitis: An inflammatory process affecting the wall of the trachea.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — J04, J05.0 Hospital discharge: ICD-9 — 464 Hospital discharge: ICD-8 — 464\|50803 Hospital discharge: excluded ICD-9 — 4643 Hospital discharge: excluded ICD-8 — 46404 Cause of death: ICD-10 — J04, J05.0 Cause of death: ICD-9 — 464 Cause of death: ICD-8 — 464\|50803 Cause of death: excluded ICD-9 — 4643 Cause of death: excluded ICD-8 — 46404 2 out of 7 registries used, show all original rules.	6979
4. Check minimum number of events None	6979
5. Include endpoints None	6979
6. Filter based on genotype QC (FinnGen only)	6374

Control definitions (FinnGen only)

Control exclude: J10_UPPERINFEC

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2

NAME	J10_LARYNGITIS
CONTROL_EXCLUDE	J10_UPPERINFEC
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	J04\|J050
HD_ICD_9	464
HD_ICD_8	464\|50803
HD_ICD_10_EXCL
HD_ICD_9_EXCL	4643
HD_ICD_8_EXCL	46404
COD_MAINONLY
COD_ICD_10	J04\|J050
COD_ICD_9	464
COD_ICD_8	464\|50803
COD_ICD_10_EXCL
COD_ICD_9_EXCL	4643
COD_ICD_8_EXCL	46404
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Acute laryngitis and tracheitis based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	128212	46953	81099
Only index persons	93013	34477	58536
Unadjusted period prevalence (%)
Whole population	1.93	1.34	2.27
Only index persons	1.88	1.27	2.23
Median age at first event (years)
Whole population	2.45	2.67	2.25
Only index persons	2.67	3.09	2.42

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	6374	3612	2762
Unadjusted period prevalence (%)	1.28	1.28	1.27
Median age at first event (years)	6.22	8.04	3.83

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
6495: Matched controls
63927

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

4640A

ICD-9 Finland

Acute laryngitis and tracheitis, Acute laryngitis

+∞

307.7

1243

J04.0

ICD-10 Finland

Acute laryngitis

74.9

307.7

3314

877

46401

ICD-8 Finland

Acute laryngitis and tracheitis, Laryngitis acuta (subglottica)

+∞

307.7

1264

J05.0

ICD-10 Finland

Acute obstructive laryngitis [croup]

608.5

299.0

296

J04.2

ICD-10 Finland

Acute laryngotracheitis

15.6

248.4

219

143

J03.9

ICD-10 Finland

Acute tonsillitis, unspecified

5.0

245.5

559

1174

46599

ICD-8 Finland

Acute upper respiratory infection of multiple or unspecified sites

+∞

224.0

215

46409

ICD-8 Finland

Acute laryngitis and tracheitis, Unspecified

+∞

224.0

215

J37.0

ICD-10 Finland

Chronic laryngitis

6.3

188.0

326

530

UDQ12

NOMESCO Finland

Flexible laryngoscopy

4.5

175.6

458

1069

J45.9

ICD-10 Finland

Asthma, unspecified

2.5

170.0

1261

5552

R03AC02

ATC

salbutamol; inhalant

2.0

166.4

3721

25327

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

2.5

166.2

1291

5802

R03BA05

ATC

fluticasone; inhalant

2.4

155.2

1376

6541

J01.0

ICD-10 Finland

Acute maxillary sinusitis

2.2

154.7

1801

9581

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

2.0

149.5

4232

30783

H02AB06

ATC

prednisolone; systemic

2.0

146.0

2629

16343

4659X

ICD-9 Finland

Acute upper respiratory infections of multiple or unspecified sites, Unspecified site

+∞

138.2

133

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.3

137.0

1227

5827

TDM10

NOMESCO Finland

Puncture of maxillary antrum

6.0

134.8

244

413

J46

ICD-10 Finland

Status asthmaticus

6.4

133.1

226

359

38100

ICD-8 Finland

Otitis media without mention of mastoiditis, Acute

4.9

126.0

288

602

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.7

125.7

783

3136

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.6

121.5

809

3346

J45.1

ICD-10 Finland

Nonallergic asthma

3.2

119.1

519

1710

4610A

ICD-9 Finland

Acute sinusitis, Maxillary

+∞

117.4

113

R03DC03

ATC

montelukast; oral

2.2

114.3

1128

5540

UDH02

NOMESCO Finland

Rhinopharyngoscopy

3.3

111.1

437

1352

J04.1

ICD-10 Finland

Acute tracheitis

14.2

109.7

101

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

2.7

107.7

625

2408

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.8

104.2

2158

13675

J04

ICD-10 Finland

Acute laryngitis and tracheitis

8.5

103.9

136

161

J01FA10

ATC

azithromycin; systemic

1.8

102.6

4101

31374

R03BA02

ATC

budesonide; inhalant

2.1

100.8

1166

6064

R49.01

ICD-10 Finland

Functional dysphonia

4.5

97.2

242

542

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.8

95.2

2424

16218

R06.0

ICD-10 Finland

Dyspnoea

2.0

92.2

1321

7391

J05.1

ICD-10 Finland

Acute epiglottitis

301.8

88.4

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.0

86.6

1162

6343

R49.08

ICD-10 Finland

Other specified dysphonia

5.1

85.1

182

359

J01AA02

ATC

doxycycline; systemic

1.7

85.0

4004

31234

46100

ICD-8 Finland

Acute sinusitis, Maxillaris

+∞

82.0

J01FA06

ATC

roxithromycin; oral

1.7

81.6

1964

12810

J01FA09

ATC

clarithromycin; systemic

1.7

81.5

1848

11852

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

4.6

81.2

199

440

R06AE07

ATC

cetirizine; oral

1.7

81.1

2913

21104

4630A

ICD-9 Finland

Acute tonsillitis[TONSILLITIS ACUTA]

+∞

77.8

H02AB04

ATC

methylprednisolone; systemic

2.2

77.0

693

3245

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.7

75.8

429

1624

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.6

74.9

3447

26354

R01AD09

ATC

mometasone; nasal

1.6

72.9

2837

20782

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.6

72.1

248

702

4642A

ICD-9 Finland

Acute laryngitis and tracheitis, Acute laryngotracheitis

+∞

70.5

3820A

ICD-9 Finland

Suppurative and unspecified otitis media, Acute suppurative otitis media

3.8

70.1

224

603

R50.9

ICD-10 Finland

Fever, unspecified

1.9

69.3

941

5124

R51.80

ICD-10 Finland

Headache

1.8

67.2

1131

6594

R03AC03

ATC

terbutaline; inhalant

2.0

67.2

826

4344

J01FF01

ATC

clindamycin; systemic

1.7

66.5

1372

8492

C01CA24

ATC

epinephrine; parenteral

2.3

66.3

519

2286

J45

ICD-10 Finland

Asthma

2.1

66.0

660

3214

R03AK07

ATC

formoterol and budesonide; inhalant

1.8

65.5

1264

7673

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.8

65.0

1238

7485

N02AX02

ATC

tramadol; systemic, rectal

1.6

64.5

1935

13205

R01AD08

ATC

fluticasone; nasal

1.7

62.6

1668

11036

J03.0

ICD-10 Finland

Streptococcal tonsillitis

2.7

61.5

342

1281

R05

ICD-10 Finland

Cough

1.7

61.4

1238

7592

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

3.0

60.2

271

905

4644A

ICD-9 Finland

Acute laryngitis and tracheitis, Croup

+∞

60.1

J38.4

ICD-10 Finland

Oedema of larynx

11.4

60.0

A02BC05

ATC

esomeprazole; systemic

1.6

59.5

1900

13112

J01DA01

ATC

[U] cefalexin

1.5

57.8

3404

26851

R03BB04

ATC

tiotropium bromide; inhalant

2.6

57.6

339

1306

J45.8

ICD-10 Finland

Mixed asthma

3.6

56.9

190

527

J21.9

ICD-10 Finland

Acute bronchiolitis, unspecified

3.7

56.8

184

500

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

56.7

1362

8740

R03AK08

ATC

formoterol and beclometasone; inhalant

3.0

56.2

258

871

R03BA01

ATC

beclometasone; inhalant

2.0

56.2

680

3544

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.7

56.0

1429

9309

R02

ICPC

Shortness of breath/dyspnoea

2.0

55.9

689

3614

J01DB01

ATC

cefalexin; oral

1.6

55.6

5077

43907

R03CC02

ATC

salbutamol; systemic

1.8

55.4

869

4934

R96

ICPC

Asthma

2.2

55.3

525

2500

J01MA12

ATC

levofloxacin; systemic

1.9

55.1

719

3846

R03BA08

ATC

ciclesonide; inhalant

2.2

53.2

478

2226

R49.0

ICD-10 Finland

Dysphonia

3.7

52.8

173

474

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.9

52.7

800

4492

H02AB07

ATC

prednisone; oral

2.0

52.6

578

2908

H66.9

ICD-10 Finland

Otitis media, unspecified

1.9

50.5

669

3592

R06.2

ICD-10 Finland

Wheezing

2.6

50.3

315

1251

R01AD12

ATC

fluticasone furoate; nasal

1.5

49.7

2084

15162

R06AX27

ATC

desloratadine; oral

1.5

48.8

2027

14703

R03AC12

ATC

salmeterol; inhalant

3.2

48.8

195

607

A02BC02

ATC

pantoprazole; systemic

1.5

48.4

3273

26160

4939X

ICD-9 Finland

Asthma, unspecified[ASTHMA BRONCHIALE NUD]

4.2

48.4

130

309

R03DA04

ATC

theophylline; systemic, rectal

3.1

48.2

203

652

4600A

ICD-9 Finland

Acute nasopharyngitis [common cold][NASOPHARYNGITIS ACUTA]

+∞

47.7

J38.3

ICD-10 Finland

Other diseases of vocal cords

5.6

47.1

157

46309

ICD-8 Finland

Acute tonsillitis, Unspecified

+∞

46.6

J20

ICD-10 Finland

Acute bronchitis

1.9

44.8

581

3092

XQ800

NOMESCO Finland

Prick test

2.0

44.5

530

2739

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

2.3

44.0

368

1662

J38.0

ICD-10 Finland

Paralysis of vocal cords and larynx

4.7

43.7

101

213

M79.6

ICD-10 Finland

Pain in limb

1.5

43.4

2367

18029

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

43.4

2077

15424

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.2

43.0

394

1847

R01AD58

ATC

fluticasone, combinations; nasal

1.5

42.9

1675

11926

J01FA15

ATC

telithromycin; oral

2.1

42.9

437

2133

R05FB02

ATC

cough suppressants and expectorants; systemic

1.5

42.7

1450

10020

A02BC01

ATC

omeprazole; systemic

1.6

42.4

1178

7772

M01AE02

ATC

naproxen; oral, rectal

1.4

42.2

3444

28206

46699

ICD-8 Finland

Acute bronchitis and bronchiolitis

4.0

41.9

120

299

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.7

41.6

965

6087

T78.4

ICD-10 Finland

Allergy, unspecified

2.3

41.5

341

1529

50803

ICD-8 Finland

Other diseases of upper respiratory tract, Pseudocroup

+∞

41.5

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.5

41.4

1876

13756

EMB10

NOMESCO Finland

Tonsillectomy

2.0

41.0

483

2484

R05FA02

ATC

opium derivatives and expectorants; systemic

1.5

40.8

1930

14261

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.8

40.8

729

4281

A07AA02

ATC

nystatin; oral

2.6

40.7

237

908

N03AX16

ATC

[U] pregabalin

1.7

40.5

916

5736

A02BA02

ATC

ranitidine; systemic

1.8

40.1

637

3611

4930A

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]

4.9

40.0

178

R05

ICPC

Cough

1.5

40.0

1456

10192

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

39.9

1243

8409

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.9

39.7

570

3131

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.4

39.5

277

1159

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

39.1

818

5016

R07.0

ICD-10 Finland

Pain in throat

1.8

38.6

577

3209

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.5

38.4

1510

10730

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

37.8

1140

7645

R23

ICPC

Voice symptom/complaint

3.0

37.8

174

589

AA1AD

NOMESCO Finland

CT of head and brain

1.6

36.8

1031

6792

N02BE01

ATC

paracetamol; systemic, rectal

1.5

36.5

5054

44924

R21

ICPC

Throat symptom/complaint

1.4

36.4

1858

13868

4859X

ICD-9 Finland

Bronchopneumonia, organism unspecified[PNEUMONIA NUD]

3.3

36.3

139

422

M25.5

ICD-10 Finland

Pain in joint

1.5

36.3

1789

13265

J02AC01

ATC

fluconazole; systemic

1.4

35.9

1972

14910

XG410

NOMESCO Finland

Flow-volume spirometry

2.7

35.7

193

712

R03AC13

ATC

formoterol; inhalant

2.6

35.7

208

797

J01MA02

ATC

ciprofloxacin; systemic

1.5

35.7

1584

11505

J01DA09

ATC

[U] cefadroxil

1.5

35.5

1378

9741

J01CA04

ATC

amoxicillin; systemic

1.5

35.4

5416

48918

46403

ICD-8 Finland

Acute laryngitis and tracheitis, Laryngotracheitis acuta purulenta

+∞

35.2

N05BA01

ATC

diazepam; systemic, rectal

1.8

34.9

568

3239

M03BC01

ATC

orphenadrine (citrate); systemic

1.5

34.8

1142

7787

R07.4

ICD-10 Finland

Chest pain, unspecified

1.5

34.7

1130

7693

49099

ICD-8 Finland

Bronchitis, unspecified

5.4

34.6

128

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

3.0

34.6

156

522

R03BC03

ATC

nedocromil; inhalant

2.2

34.5

295

1344

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.3

33.9

260

1131

50099

ICD-8 Finland

Hypertrophy of tonsils and adenoids

1.9

33.8

469

2546

J01FA01

ATC

erythromycin; systemic

1.6

33.6

932

6117

M54.5

ICD-10 Finland

Low back pain

1.4

33.5

2040

15667

J01.4

ICD-10 Finland

Acute pansinusitis

12.0

33.5

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.4

33.3

235

986

R03BB01

ATC

ipratropium bromide; inhalant

3.5

33.2

113

318

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

33.1

1107

7571

UJF32

NOMESCO Finland

Coloscopy

1.6

33.0

927

6099

R06AX13

ATC

loratadine; oral

1.6

32.5

924

6095

R01BA52

ATC

pseudoephedrine, combinations; oral

1.5

32.4

1169

8123

R06AE09

ATC

levocetirizine; oral

1.6

32.4

895

5864

R42

ICD-10 Finland

Dizziness and giddiness

1.6

32.2

952

6332

DQB10

NOMESCO Finland

Endoscopic excision of lesion of larynx

5.9

32.1

N03AX12

ATC

[U] gabapentin; oral

1.7

32.0

641

3873

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.0

32.0

365

1855

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.8

31.9

465

2562

J06.0

ICD-10 Finland

Acute laryngopharyngitis

4.0

31.8

227

SPAT1263

SPAT

Sampling

1.4

31.8

2362

18715

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.7

31.7

587

3471

XG474

NOMESCO Finland

Exhalation nntrogen oxide

2.8

31.7

163

586

UDC00

NOMESCO Finland

Ear microscopy

2.0

31.7

381

1972

M03BX02

ATC

tizanidine; oral

1.4

31.5

3229

26905

Z3226

NOMESCO Finland

Physiotherapist

1.6

31.5

845

5494

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.5

31.5

1405

10175

R13

ICD-10 Finland

Dysphagia

2.1

31.2

292

1378

M01AE03

ATC

ketoprofen; systemic, rectal

1.5

31.2

1374

9923

48609

ICD-8 Finland

Pneumonia, unspecified

3.9

31.2

239

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.9

31.0

390

2049

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.6

31.0

796

5123

ZXA10

NOMESCO Finland

Bilateral

1.6

30.8

719

4521

S06.0

ICD-10 Finland

Concussion

1.7

30.7

649

3978

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

9.6

30.6

4660A

ICD-9 Finland

Acute bronchitis and bronchiolitis, Acute bronchitis

3.9

30.4

226

S01GX01

ATC

cromoglicic acid; ophthalmic

1.5

30.3

1277

9141

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.9

30.3

375

1960

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.2

30.2

267

1232

3810A

ICD-9 Finland

Nonsuppurative otitis media and Eustachian tube disorders, Acute nonsuppurative otitis media

4.4

30.0

169

J00

ICD-10 Finland

Acute nasopharyngitis [common cold]

2.8

29.7

151

540

P01AB01

ATC

metronidazole; oral, rectal

1.4

29.4

1906

14719

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.6

29.4

169

644

J01DA06

ATC

[U] cefuroxime

1.6

28.9

663

4148

A02BC03

ATC

lansoprazole; oral

1.5

28.5

1011

6982

X58

ICD-10 Finland

Exposure to other specified factors

1.5

28.2

948

6473

4451

FHL

Guitar cutting

1.9

28.1

349

1825

Z3231

NOMESCO Finland

Registered nurse

1.4

27.9

1326

9687

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

6.4

27.9

R49.8

ICD-10 Finland

Other and unspecified voice disturbances

4.0

27.8

192

XF400

NOMESCO Finland

ECG with 12 standard connections

1.7

27.8

569

3454

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.1

27.8

261

1234

R01AD05

ATC

budesonide; nasal

1.9

27.8

358

1896

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.0

27.4

318

1625

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.8

27.4

455

2607

J21.90

ICD-10 Finland

Acute obstructive bronchitis in children

5.0

27.3

114

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

1.7

27.1

571

3492

ZX120

NOMESCO Finland

Intravenous

1.9

27.0

371

2006

J01MA14

ATC

moxifloxacin; systemic

2.0

26.9

322

1662

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.4

26.5

188

791

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.8

26.3

426

2423

L03

ICPC

Low back symptom/complaint

1.4

26.2

1644

12584

R53

ICD-10 Finland

Malaise and fatigue

1.4

26.2

1383

10284

A03FA02

ATC

cisapride; oral, rectal

2.0

26.1

273

1344

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.5

26.0

889

6083

46099

ICD-8 Finland

Acute nasopharyngitis (common cold)

+∞

25.9

M54.4

ICD-10 Finland

Lumbago with sciatica

1.5

25.9

861

5859

A01AB09

ATC

miconazole; local oral

1.8

25.8

373

2048

J01DA08

ATC

[U] cefaclor

1.5

25.5

991

6958

G47.3

ICD-10 Finland

Sleep apnoea

1.5

25.3

964

6740

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.6

25.3

559

3459

N05BA04

ATC

oxazepam; oral

1.4

25.1

1242

9119

C03CA01

ATC

furosemide; systemic

1.6

24.9

684

4460

B34.9

ICD-10 Finland

Viral infection, unspecified

2.1

24.8

233

1103

N06AX21

ATC

duloxetine; oral

1.6

24.6

581

3655

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

24.6

1137

8245

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.7

24.5

465

2763

DQA10

NOMESCO Finland

Biopsy of larynx

6.8

24.5

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.0

24.3

278

1414

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

24.2

680

4455

R03DC01

ATC

zafirlukast; oral

4.2

24.2

151

TPH04

NOMESCO Finland

Cathetrisation of vein

1.5

24.2

933

6537

E66.01

ICD-10 Finland

Obesity due to excess calories

1.6

24.1

562

3523

R06.1

ICD-10 Finland

Stridor

6.5

24.1

4930B

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA CUM EXACERBATIONE]

5.4

24.0

R74

ICPC

Upper respiratory infection acute

1.3

23.9

2522

20803

A03

ICPC

Fever

1.4

23.9

1294

9643

R11

ICD-10 Finland

Nausea and vomiting

1.7

23.7

495

3017

J35.0

ICD-10 Finland

Chronic tonsillitis

1.8

23.6

393

2252

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

3.1

23.5

309

J02

ICD-10 Finland

Acute pharyngitis

1.8

23.5

366

2057

Z00.0

ICD-10 Finland

General medical examination

1.4

23.3

1057

7630

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.6

23.3

642

4187

49300

ICD-8 Finland

Asthma, bronchiale

3.4

23.2

242

J01.1

ICD-10 Finland

Acute frontal sinusitis

3.5

23.0

229

L28

ICPC

Limited function/disability (L)

1.6

22.9

593

3810

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

3.1

22.9

309

ZXE00

NOMESCO Finland

One hour or less

1.3

22.8

1878

14928

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.5

22.8

832

5759

4620A

ICD-9 Finland

Acute pharyngitis[PHARYNGITIS ACUTA]

+∞

22.8

DNB20

NOMESCO Finland

Endoscopic ethmoidectomy

2.9

22.8

106

362

R06AX22

ATC

ebastine; oral

1.5

22.8

879

6153

SPAT1310

SPAT

Counselling related to known health issue

1.3

22.8

1710

13411

DMB00

NOMESCO Finland

Endonasal trephine of maxillary antrum

5.0

22.5

UJC01

NOMESCO Finland

Scopy of lower throat

5.0

22.5

R01AD59

ATC

mometasone, combinations; nasal

1.7

22.5

468

2851

J21.0

ICD-10 Finland

Acute bronchiolitis due to respiratory syncytial virus

3.8

22.4

173

ZXD10

NOMESCO Finland

Scheduled procedure

1.4

22.4

1592

12373

N02AJ06

ATC

codeine and paracetamol; systemic

1.3

22.4

2187

17802

1240

FHL

Bronchoscopy

4.8

22.4

103

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

3.8

22.3

174

T78.2

ICD-10 Finland

Anaphylactic shock, unspecified

3.5

22.2

220

H02AB09

ATC

hydrocortisone; systemic

2.6

22.2

133

518

E0000UV, ,

ATC

1.3

22.1

2383

19653

R06.4

ICD-10 Finland

Hyperventilation

2.9

22.1

101

342

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.3

22.0

1792

14212

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

21.9

2520

20954

J01.9

ICD-10 Finland

Acute sinusitis, unspecified

2.0

21.9

226

1108

G43.9

ICD-10 Finland

Migraine, unspecified

1.7

21.8

437

2634

J05AB01

ATC

aciclovir; systemic

1.4

21.8

1015

7352

TFC99

NOMESCO Finland

Catheterisation of heart with other procedure

8.2

21.8

C07AB07

ATC

bisoprolol; oral

1.4

21.6

1467

11315

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.8

21.6

345

1953

N06AX11

ATC

mirtazapine; oral

1.3

21.6

1655

13002

H01

ICPC

Ear pain/earache

1.5

21.5

837

5865

N05CF01

ATC

zopiclone; oral

1.4

21.4

1176

8766

DCA20

NOMESCO Finland

Insertion of ventilating tube through tympanic membrane

1.8

21.3

304

1662

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.7

21.3

411

2453

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.5

21.3

867

6126

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.8

21.2

336

1897

G44.2

ICD-10 Finland

Tension-type headache

1.5

21.1

728

4977

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

21.1

2127

17354

J01

ICD-10 Finland

Acute sinusitis

1.8

21.0

314

1743

M70.6

ICD-10 Finland

Trochanteric bursitis

1.7

20.9

423

2558

R52.9

ICD-10 Finland

Pain, unspecified

1.6

20.9

503

3177

S80.0

ICD-10 Finland

Contusion of knee

1.6

20.7

456

2816

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.6

20.7

472

2940

46400, ,

ICD-8 Finland

+∞

20.7

J02.0

ICD-10 Finland

Streptococcal pharyngitis

2.0

20.7

230

1158

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

20.6

1020

7465

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

20.5

240

1231

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.9

20.3

268

1430

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.7

20.3

420

2553

UDQ02

NOMESCO Finland

Direct laryngoscopy

4.4

20.3

116

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

1.8

20.2

282

1533

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.8

20.2

326

1852

XF600

NOMESCO Finland

Bloodpressure measurement

1.8

20.1

285

1556

R4130

NOMESCO Finland

Speech therapy

2.5

20.0

123

486

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.5

19.9

619

4139

R49.09

ICD-10 Finland

Unspecified dysphonia

3.8

19.9

156

R01AD11

ATC

triamcinolone; nasal

1.7

19.8

375

2227

EMB30

NOMESCO Finland

Adenotomy

1.7

19.7

371

2199

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.6

19.6

433

2675

M02AA07

ATC

piroxicam; topical

1.4

19.6

1187

8975

N02AA05

ATC

oxycodone; systemic

1.6

19.6

490

3122

SPAT1301

SPAT

No procedures

1.3

19.6

1534

12060

A03FA01

ATC

metoclopramide; systemic, rectal

1.4

19.5

879

6320

UGC02

NOMESCO Finland

Rigid bronchoscopy

6.7

19.5

SPAT1254

SPAT

Administration of medicine

1.5

19.5

780

5487

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

2.7

19.5

102

372

M01AH05

ATC

etoricoxib; oral

1.3

19.4

3079

26524

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.5

19.4

592

3944

J01DC02

ATC

cefuroxime; systemic

1.9

19.3

258

1384

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

2.4

19.2

131

543

N06AB04

ATC

citalopram; systemic

1.4

19.2

865

6221

ZXE10

NOMESCO Finland

More than one and less than three hours

1.3

19.0

1439

11252

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

4.4

18.9

106

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

18.8

4663

42342

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.4

18.8

967

7114

J01CE02

ATC

phenoxymethylpenicillin; oral

1.3

18.7

4179

37436

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.9

18.7

241

1277

J38.7

ICD-10 Finland

Other diseases of larynx

4.5

18.6

D01

ICPC

Abdominal pain/cramps general

1.4

18.6

814

5818

4641A

ICD-9 Finland

Acute laryngitis and tracheitis, Acute tracheitis

+∞

18.6

46499, ,

ICD-8 Finland

+∞

18.6

M79.7

ICD-10 Finland

Fibromyalgia

2.2

18.6

163

751

R4110

NOMESCO Finland

Physiotherapy

1.4

18.6

1167

8863

UDM02

NOMESCO Finland

Sinoscopy

2.9

18.6

299

602

Kela drug reimbursment

Children's severe malnutrition

4.1

18.5

120

L50.9

ICD-10 Finland

Urticaria, unspecified

1.9

18.5

245

1309

Z00.8

ICD-10 Finland

Other general examinations

1.6

18.4

453

2874

N05AH04

ATC

quetiapine; oral

1.4

18.4

1061

7954

Z3229

NOMESCO Finland

Other healthcare associate professional

1.7

18.4

330

1932

A01AB04

ATC

amphotericin B; local oral

2.4

18.4

125

518

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.6

18.3

103

390

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.7

18.3

363

2183

R00.2

ICD-10 Finland

Palpitations

1.6

18.3

420

2621

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

18.2

2647

22501

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

2.3

18.2

133

569

L20.0

ICD-10 Finland

Besnier prurigo

1.5

18.2

633

4333

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

3.7

18.1

153

ZX108

NOMESCO Finland

Inhalation

5.3

18.1

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.6

18.1

393

2420

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.0

18.0

183

893

EN1AD

NOMESCO Finland

CT examination of mouth and soft tissues of neck

3.7

18.0

154

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.6

18.0

468

3009

A06AD11

ATC

lactulose; oral

1.6

18.0

439

2781

J98.0

ICD-10 Finland

Diseases of bronchus, not elsewhere classified

7.7

17.9

XF622

NOMESCO Finland

Measurement of minute volume of heart

7.3

17.9

R01BA51

ATC

phenylpropanolamine, combinations; oral

1.4

17.8

891

6522

E66.8

ICD-10 Finland

Other obesity

1.8

17.7

295

1692

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.6

17.6

451

2888

SPAT1283

SPAT

Restricted health certificate

1.3

17.6

1440

11363

N03AG01

ATC

valproic acid; systemic, rectal

1.7

17.6

308

1791

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.6

17.6

436

2772

ZYC01

NOMESCO Finland

Remote contact by phone

1.7

17.5

337

2009

A46

ICD-10 Finland

Erysipelas

1.6

17.5

480

3121

RD210, ,

NOMESCO Finland

2.3

17.5

126

536

7803A

ICD-9 Finland

General symptoms, Convulsions

2.9

17.5

277

UDQ22

NOMESCO Finland

Microlaryngoscopy

5.2

17.4

R03BC01

ATC

cromoglicic acid; inhalant

2.5

17.3

108

430

1420

FHL

Laryngomicroscopy

5.6

17.2

K59.09

ICD-10 Finland

Constipation, unspecified

1.8

17.1

240

1306

R55

ICD-10 Finland

Syncope and collapse

1.6

17.1

397

2483

R03CC03

ATC

terbutaline; systemic

1.8

17.1

259

1444

WX110

NOMESCO Finland

Infiltration anesthesia

1.3

17.1

4491

40771

L04AA01

ATC

[U] ciclosporin

3.7

17.0

146

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.5

17.0

644

4479

00920

ICD-8 Finland

Diarrhoeal disease, Gastroenteritis (acuta) (infectiosa)

2.2

17.0

139

624

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.3

16.9

3085

26837

B01AB05

ATC

enoxaparin; parenteral

1.4

16.9

1071

8135

S18

ICPC

Laceration/cut

1.3

16.6

2118

17672

M03BC51

ATC

orphenadrine, combinations; systemic

1.3

16.6

1154

8888

Z71.8

ICD-10 Finland

Other specified counselling

1.3

16.6

1996

16538

M54.6

ICD-10 Finland

Pain in thoracic spine

1.6

16.5

400

2527

7819X

ICD-9 Finland

Symptoms involving nervous and musculoskeletal systems, Other symptoms involving nervous and musculoskeletal systems[SYMPTOMATA ALIA SYSTEMATIS NERVORUM ET MUSCULOSCEL]

4.1

16.5

105

J36

ICD-10 Finland

Peritonsillar abscess

1.9

16.5

197

1019

J11.1

ICD-10 Finland

Influenza with other respiratory manifestations, virus not identified

2.3

16.4

128

563

J31.0

ICD-10 Finland

Chronic rhinitis

1.6

16.4

422

2704

AA5HE

NOMESCO Finland

Brain ultrasound examination in a child

4.3

16.4

WX882

NOMESCO Finland

High dependency care

2.2

16.3

138

628

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.1

16.3

151

712

WZC30

NOMESCO Finland

Teaching

1.5

16.3

611

4239

Z2446

NOMESCO Finland

Social worker

1.6

16.3

382

2395

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.4

16.3

743

5346

R01AD01

ATC

beclometasone; nasal

1.4

16.2

642

4500

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.5

16.2

100

396

M48.0

ICD-10 Finland

Spinal stenosis

1.7

16.2

282

1636

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.3

16.1

1590

12842

JN3AD

NOMESCO Finland

Abdominal CT examination

1.5

16.1

481

3187

4452

FHL

Tonsil surgery

2.0

16.1

167

822

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.5

16.1

489

3253

H65.3

ICD-10 Finland

Chronic mucoid otitis media

1.8

15.9

234

1293

K30

ICD-10 Finland

Functional dyspepsia

1.5

15.9

523

3535

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.5

15.9

471

3115

D11

ICPC

Diarrhoea

1.4

15.9

774

5631

O99.5

ICD-10 Finland

Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium

3.5

15.9

153

A04

ICPC

Weakness/tiredness general

1.4

15.8

902

6735

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.3

15.7

114

487

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

1.6

15.6

327

1994

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.8

15.6

234

1301

R03AK11

ATC

formoterol and fluticasone; inhalant

2.4

15.6

105

434

4658X

ICD-9 Finland

Acute upper respiratory infections of multiple or unspecified sites, Other multiple sites

+∞

15.5

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.4

15.5

886

6616

J38.2

ICD-10 Finland

Nodules of vocal cords

4.0

15.5

110

SPAT1059

SPAT

Spirometry at the office

2.0

15.5

176

895

N02BF02

ATC

pregabalin; oral

1.7

15.4

288

1706

J20.5

ICD-10 Finland

Acute bronchitis due to respiratory syncytial virus

6.8

15.4

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.5

15.3

441

2898

WX002

NOMESCO Finland

Sedation and analgesia

1.4

15.3

651

4627

J38.5

ICD-10 Finland

Laryngeal spasm

5.9

15.2

Z2221

NOMESCO Finland

Medical doctor

1.3

15.2

1270

10023

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.5

15.2

459

3049

4221

FHL

Polyp removal from the nasal cavity, sinus puncture or irrigation, or biopsy under general anesthesia or operating room

3.8

15.1

121

4742A

ICD-9 Finland

Chronic disease of tonsils and adenoids, Adenoid vegetations

1.9

15.1

175

896

M79.1

ICD-10 Finland

Myalgia

1.4

15.1

784

5765

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.1

15.1

150

728

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.5

15.0

460

3063

R60.0

ICD-10 Finland

Localized oedema

1.5

15.0

412

2679

M01AB05

ATC

diclofenac; systemic, rectal

1.2

15.0

3105

27244

R07.3

ICD-10 Finland

Other chest pain

1.5

15.0

418

2728

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

1.9

15.0

173

885

ZXD05

NOMESCO Finland

Urgent procedure

1.3

14.9

1413

11337

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.5

14.9

530

3640

N06AX16

ATC

venlafaxine; oral

1.4

14.8

766

5627

N06AB10

ATC

escitalopram; oral

1.3

14.8

1301

10335

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.4

14.8

402

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.4

14.7

622

4412

SPAT1153

SPAT

Removal of sutures

1.3

14.7

1137

8875

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

1.7

14.7

245

1406

FM2CE, ,

NOMESCO Finland

2.9

14.7

233

D07AA02

ATC

hydrocortisone; topical

1.4

14.6

864

6483

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.6

14.6

373

2387

H92.0

ICD-10 Finland

Otalgia

1.5

14.6

398

2587

A06AC01

ATC

ispaghula (psylla seeds); oral

1.3

14.5

939

7143

M01AX17

ATC

nimesulide; oral

1.4

14.5

644

4608

H65.1

ICD-10 Finland

Other acute nonsuppurative otitis media

2.2

14.5

125

574

4650A

ICD-9 Finland

Acute upper respiratory infections of multiple or unspecified sites, Acute laryngopharyngitis

+∞

14.5

J30.3

ICD-10 Finland

Other allergic rhinitis

1.8

14.5

226

1273

4900A

ICD-9 Finland

Bronchitis, not specified as acute or chronic[BRONCHITIS NUD]

5.8

14.5

SPAT1260

SPAT

Consultation of another employee

1.4

14.3

764

5641

R09

ICPC

Sinus symptom/complaint

1.5

14.2

446

2987

R4190

NOMESCO Finland

Nutritional therapy

1.7

14.2

245

1421

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.5

14.1

454

3055

L15

ICPC

Knee symptom/complaint

1.3

14.1

1190

9397

SPAT1312

SPAT

General health counselling

1.3

14.1

1893

15823

R03AK03

ATC

[U] fenoterol and ipratropium bromide

2.2

13.8

108

477

SFA10

NOMESCO Finland

One-surface restoration

1.2

13.8

3441

30670

L50.0

ICD-10 Finland

Allergic urticaria

2.0

13.7

150

753

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.4

13.7

839

6324

L04AX01

ATC

azathioprine; systemic

1.8

13.7

205

1140

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.8

13.7

194

1061

D14.1

ICD-10 Finland

Benign neoplasm: Larynx

4.4

13.7

E000001, ,

ATC

1.3

13.6

1080

8450

F79.0

ICD-10 Finland

Unspecified mental retardation, with the statement of no, or minimal, impairment of behaviour

4.5

13.6

H04.10

ICD-10 Finland

Dry eye syndrome

1.5

13.6

495

3412

M01AH01

ATC

celecoxib; oral

1.4

13.6

539

3778

W19

ICD-10 Finland

Unspecified fall

1.5

13.6

452

3064

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.3

13.5

854

6468

N06AA09

ATC

amitriptyline; systemic

1.7

13.5

258

1537

Z50.5

ICD-10 Finland

Speech therapy

2.4

13.5

401

N03AX09

ATC

lamotrigine; oral

1.6

13.5

311

1943

GD1AA, ,

SPAT

1.3

13.5

941

7235

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.7

13.5

275

1668

K08.80

ICD-10 Finland

Toothache NOS

1.5

13.4

498

3446

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

4.0

13.4

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.5

13.4

451

3064

J20.0

ICD-10 Finland

Acute bronchitis due to Mycoplasma pneumoniae

3.9

13.3

100

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.5

13.3

504

3503

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.3

13.3

1249

9993

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.5

13.2

363

2361

J38.6

ICD-10 Finland

Stenosis of larynx

25.4

13.2

ZXA00

NOMESCO Finland

Right side

1.3

13.2

836

6332

Q90.9

ICD-10 Finland

Down syndrome, unspecified

17.9

13.2

R56.8

ICD-10 Finland

Other and unspecified convulsions

1.6

13.2

284

1746

N03AE01

ATC

clonazepam; systemic

1.8

13.2

208

1176

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.3

13.1

1096

8632

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.4

13.1

599

4306

R5140

NOMESCO Finland

Monitoring the use of the aid

1.5

13.1

378

2486

JDB10

NOMESCO Finland

Percutaneous gastrostomy

3.7

13.0

106

N06AB03

ATC

fluoxetine; oral

1.4

13.0

543

3841

0092A

ICD-9 Finland

Ill-defined intestinal infections, Infectious diarrhoea

2.7

13.0

244

P29

ICPC

Psychological sympt/compl other

1.4

13.0

627

4552

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

1.9

13.0

152

783

K10.3

ICD-10 Finland

Alveolitis of jaws

1.6

12.9

275

1685

W22

ICD-10 Finland

Striking against or struck by other object(s)

1.5

12.9

417

2809

R06.5

ICD-10 Finland

Mouth breathing

1.5

12.8

408

2741

Z31.5

ICD-10 Finland

Genetic counselling

1.6

12.8

331

2127

N30.0

ICD-10 Finland

Acute cystitis

1.3

12.7

777

5852

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.7

12.7

224

1308

K52.2

ICD-10 Finland

Allergic and dietetic gastroenteritis and colitis

2.6

12.7

281

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.6

12.7

291

1818

J47

ICD-10 Finland

Bronchiectasis

3.4

12.6

132

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.6

12.6

294

1842

G81.9

ICD-10 Finland

Hemiplegia, unspecified

3.5

12.6

118

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.2

12.6

1649

13712

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.3

12.6

912

7045

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

3.6

12.5

109

I50.9

ICD-10 Finland

Heart failure, unspecified

1.7

12.5

245

1470

K02.1

ICD-10 Finland

Caries of dentine

1.2

12.5

3846

34832

N03AF02

ATC

oxcarbazepine; oral

1.9

12.5

163

870

J06.80

ICD-10 Finland

Continuously repeating infections of a child

15.2

12.5

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

5.3

12.5

N05CF02

ATC

zolpidem; oral

1.4

12.5

708

5274

H03AA01

ATC

levothyroxine sodium; systemic

1.3

12.5

888

6841

R29

ICPC

Respiratory symptom/complaint other

1.6

12.5

325

2091

M54.3

ICD-10 Finland

Sciatica

1.7

12.5

212

1225

R60.9

ICD-10 Finland

Oedema, unspecified

1.8

12.4

185

1028

G40.9

ICD-10 Finland

Epilepsy, unspecified

1.9

12.4

153

801

46209

ICD-8 Finland

Acute pharyngitis, Unspecified

+∞

12.4

L04AX03

ATC

methotrexate; systemic

1.5

12.4

401

2702

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.4

12.4

524

3717

ZXE20

NOMESCO Finland

More than three and less than five hours

1.5

12.4

451

3112

N01

ICPC

Headache

1.3

12.4

953

7423

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.3

12.3

1487

12248

C09CA06

ATC

candesartan; oral

1.3

12.3

893

6899

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

1.5

12.3

437

3001

P85

ICPC

Mental retardation

3.8

12.3

C07AA05

ATC

propranolol; systemic

1.3

12.2

1036

8171

E66.9

ICD-10 Finland

Obesity, unspecified

1.8

12.2

182

1013

SXA20

NOMESCO Finland

Local application of medicine to mouth

1.5

12.2

371

2470

A02BC04

ATC

rabeprazole; oral

1.5

12.1

355

2342

UJF30

NOMESCO Finland

Ileoscopy through colon

1.5

12.1

403

2730

F90.0

ICD-10 Finland

Disturbance of activity and attention

1.5

12.1

427

2927

Z50.1

ICD-10 Finland

Other physical therapy

1.8

12.1

176

972

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.3

12.0

1095

8714

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

1.7

12.0

212

1238

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.7

12.0

200

1150

N06AX12

ATC

bupropion; oral

1.4

12.0

521

3713

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.4

12.0

473

3313

A03CA02

ATC

clidinium and psycholeptics; oral

2.0

12.0

130

653

UJC12

NOMESCO Finland

Flexible oesophagoscopy

4.1

11.9

G43.8

ICD-10 Finland

Other migraine

2.2

11.9

103

475

K59.0

ICD-10 Finland

Constipation

1.7

11.9

221

1309

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.5

11.9

324

2106

ZXA05

NOMESCO Finland

Left side

1.3

11.8

767

5827

SAA03

NOMESCO Finland

Extended examination of mouth

1.2

11.8

2558

22361

G43.3

ICD-10 Finland

Complicated migraine

2.1

11.8

115

556

SPAT1058

SPAT

PEF monitoring instruction

1.6

11.7

305

1961

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.5

11.7

378

2545

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.4

11.7

509

3626

R51.81

ICD-10 Finland

Facial pain NOS

2.1

11.7

107

504

A04AA01

ATC

ondansetron; systemic, rectal

1.6

11.7

284

1799

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

2.7

11.6

213

J35.2

ICD-10 Finland

Hypertrophy of adenoids

1.6

11.6

254

1568

K59.1

ICD-10 Finland

Functional diarrhoea

1.6

11.6

237

1438

N05BB01

ATC

hydroxyzine; systemic

1.6

11.6

293

1873

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

1.5

11.6

331

2174

DHB50

NOMESCO Finland

Turbinoplasty

2.0

11.6

129

654

R04.2

ICD-10 Finland

Haemoptysis

2.2

11.5

398

Q32.0

ICD-10 Finland

Congenital tracheomalacia

29.6

11.5

GBB00

NOMESCO Finland

Tracheostomy

3.5

11.5

111

R10.0

ICD-10 Finland

Acute abdomen

1.8

11.5

154

830

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.5

11.5

306

1980

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.4

11.4

509

3641

E000002, ,

ATC

1.4

11.4

636

4721

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.4

11.3

496

3538

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.7

11.3

210

1243

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.6

11.3

245

1509

R05DA01

ATC

ethylmorphine; oral

1.6

11.3

268

1687

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.7

11.3

204

1199

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.5

11.3

323

2122

S63.5

ICD-10 Finland

Sprain and strain of wrist

1.6

11.3

231

1404

A41.9

ICD-10 Finland

Sepsis, unspecified

2.1

11.3

105

499

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.6

11.3

296

1909

L60.0

ICD-10 Finland

Ingrowing nail

1.6

11.2

258

1612

T82

ICPC

Obesity

1.6

11.2

231

1405

J05AB11

ATC

valaciclovir; oral

1.4

11.2

591

4349

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.5

11.2

387

2642

NK6MA

NOMESCO Finland

Measurement of bone age from hand and elbow using X-ray

2.2

11.2

416

V700A

ICD-9 Finland

General medical examination, Routine general medical examination at a health care facility

2.1

11.1

102

482

Q90.0

ICD-10 Finland

Trisomy 21, meiotic nondisjunction

16.8

11.1

A28

ICPC

Limited function/disability NOS

1.4

11.1

414

2871

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.9

11.0

129

665

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.4

11.0

645

4824

120

Kela drug reimbursment

Hypogammaglobulinaemia

12.5

11.0

J38.1

ICD-10 Finland

Polyp of vocal cord and larynx

3.4

10.9

110

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.8

10.9

174

988

ZXE30

NOMESCO Finland

More than five and less than seven hours

1.8

10.9

165

923

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.2

10.9

1378

11385

4224

FHL

Endonasal anthrostomy

3.5

10.9

101

1430

FHL

Laryngoscopy (direct)

42.7

10.8

Z2445

NOMESCO Finland

Psychologist

1.5

10.8

285

1839

K03.66

ICD-10 Finland

Tooth plaque

1.4

10.8

429

3007

F82

ICD-10 Finland

Specific developmental disorder of motor function

2.7

10.8

216

DCA10

NOMESCO Finland

Paracentesis of tympanic membrane

2.0

10.8

116

581

R06AX26

ATC

fexofenadine; oral

1.5

10.7

342

2298

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

1.7

10.7

184

1067

M01AC06

ATC

meloxicam; systemic, rectal

1.3

10.7

1250

10234

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.4

10.7

305

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

2.4

10.7

293

4730A

ICD-9 Finland

Chronic sinusitis, Maxillary

2.7

10.7

195

XG413

NOMESCO Finland

Spirometry with oscillometry

4.4

10.7

R28

ICPC

Limited function/disability (R)

3.0

10.7

147

48509

ICD-8 Finland

Bronchopneumonia, unspecified

2.8

10.6

179

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.7

10.6

207

1242

M54.1

ICD-10 Finland

Radiculopathy

1.8

10.6

141

758

A29

ICPC

General symptom/complaint other

1.4

10.6

530

3869

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.5

10.6

356

2420

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.7

10.5

202

1207

E66.00

ICD-10 Finland

Metabolic syndrome

1.7

10.5

203

1215

F41.3

ICD-10 Finland

Other mixed anxiety disorders

1.9

10.5

138

739

H53.1

ICD-10 Finland

Subjective visual disturbances

1.5

10.5

300

1972

C08DA01

ATC

verapamil; systemic

2.0

10.5

115

581

R77

ICPC

Laryngitis/tracheitis acute

3.5

10.4

T36

ICD-10 Finland

Poisoning by systemic antibiotics

1.6

10.4

246

1548

A11

ICPC

Chest pain NOS

1.5

10.4

298

1961

46402, ,

ICD-8 Finland

+∞

10.4

B01AA03

ATC

warfarin; systemic

1.5

10.3

362

2479

N03AF01

ATC

carbamazepine; oral, rectal

1.8

10.3

147

808

ZX114

NOMESCO Finland

Intramuscular

2.4

10.3

268

SPAT1224

SPAT

Implementation of speech therapy rehabilitation plan

2.4

10.3

274

L27.2

ICD-10 Finland

Dermatitis due to ingested food

2.0

10.2

107

531

M13.9

ICD-10 Finland

Arthritis, unspecified

1.5

10.2

300

1982

SPAT1216

SPAT

Assessment of functional ability

1.4

10.2

427

3021

T78.0

ICD-10 Finland

Anaphylactic shock due to adverse food reaction

4.4

10.2

7860A

ICD-9 Finland

Symptoms involving respiratory system and other chest symptoms, Dyspnoea and respiratory abnormalities[DYSPNOEA]

4.6

10.2

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.5

10.2

339

2298

N06AX26

ATC

vortioxetine; oral

1.4

10.2

506

3688

A01

ICPC

Pain general/multiple sites

1.4

10.2

397

2776

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.2

10.1

1296

10711

201

Kela drug reimbursment

Chronic cardiac insufficiency

1.9

10.1

122

636

WZA90

NOMESCO Finland

Other medical or dental certificate

1.2

10.1

1342

11134

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

2.5

10.1

247

C07AB02

ATC

metoprolol; systemic

1.4

10.1

459

3296

TJD20

NOMESCO Finland

Change of gastrostomy tube

5.1

10.1

SPAT1360

SPAT

Extensive global examination

1.6

10.1

240

1515

N06BA04

ATC

methylphenidate; oral

1.5

10.1

368

2542

R07

ICPC

Sneezing/nasal congestion

1.4

10.1

444

3173

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.5

10.0

280

1833

Y0499

ICD-8 Finland

Investigation of respiratory system

3.9

10.0

I50.0

ICD-10 Finland

Congestive heart failure

1.9

9.9

126

668

R35

ICD-10 Finland

Polyuria

1.6

9.9

212

1303

WX892

NOMESCO Finland

Monitored bed care

1.5

9.9

260

1678

4661A

ICD-9 Finland

Acute bronchitis and bronchiolitis, Acute bronchiolitis

4.0

9.9

J03

ICD-10 Finland

Acute tonsillitis

1.6

9.8

211

1300

78020

ICD-8 Finland

Certain symptoms referable to nervous system and special senses, Convulsions

2.6

9.8

210

I49.4

ICD-10 Finland

Other and unspecified premature depolarization

1.8

9.8

132

714

K07.60

ICD-10 Finland

Snapping jaw

1.5

9.8

291

1930

SCA02

NOMESCO Finland

Preventive oral health care

1.3

9.7

850

6717

R04.0

ICD-10 Finland

Epistaxis

1.6

9.7

225

1410

D02AX

ATC

Other emollients and protectives

1.7

9.7

179

1059

A07EC01

ATC

sulfasalazine; oral, rectal

1.5

9.7

308

2068

B27.9

ICD-10 Finland

Infectious mononucleosis, unspecified

2.7

9.7

188

ACC51

NOMESCO Finland

Release of median nerve

1.5

9.7

259

1677

D06AX01

ATC

fusidic acid; topical

1.4

9.7

472

3430

P06

ICPC

Sleep disturbance

1.3

9.7

719

5564

N02CC04

ATC

rizatriptan; oral

1.5

9.6

281

1855

J33.8

ICD-10 Finland

Other polyp of sinus

2.5

9.6

235

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

1.8

9.6

131

711

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

3.0

9.6

130

DPA25

NOMESCO Finland

Trephine of frontal sinus through nose

3.8

9.6

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

2.1

9.6

430

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

2.0

9.6

105

531

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

2.1

9.5

398

SCA01

NOMESCO Finland

Preventive oral health care, short

1.2

9.5

2229

19510

K12.00

ICD-10 Finland

Recurrent oral aphthae

2.1

9.5

392

WZC00

NOMESCO Finland

Treatment plan or consultation

1.2

9.5

2015

17484

UJD02

NOMESCO Finland

Gastroscopy

1.8

9.5

138

764

N05CD07

ATC

temazepam; oral

1.5

9.4

255

1656

4122

FHL

Tympanostomy (tympanic tube)

1.7

9.4

154

882

N02BF01

ATC

gabapentin; oral

1.4

9.4

375

2631

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

1.5

9.4

298

2002

F45.8

ICD-10 Finland

Other somatoform disorders

1.4

9.4

423

3034

D07AC13

ATC

mometasone; topical

1.2

9.4

1228

10166

A07AA09

ATC

vancomycin; oral

2.8

9.4

153

R06AX11

ATC

astemizole; oral

1.7

9.4

169

995

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.3

9.4

540

4030

NG4AA

NOMESCO Finland

Lower leg X-ray examination

1.7

9.3

152

870

O47.0

ICD-10 Finland

False labour before 37 completed weeks of gestation

1.4

9.3

494

3638

D07AB02

ATC

hydrocortisone butyrate; topical

1.2

9.3

1378

11550

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.2

9.3

1051

8559

E86

ICD-10 Finland

Volume depletion

2.3

9.3

275

Q23.4

ICD-10 Finland

Hypoplastic left heart syndrome

29.6

9.3

M01AG02

ATC

tolfenamic acid; oral, rectal

1.3

9.3

585

4421

NF1AA

NOMESCO Finland

Hip X-ray examination

1.6

9.3

214

1340

A06AC51

ATC

ispaghula, combinations; oral

1.7

9.3

157

908

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.3

9.3

547

4094

UKC02

NOMESCO Finland

Cystoscopy

1.4

9.3

380

2680

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.1

9.3

409

L17

ICPC

Foot/toe symptom/complaint

1.2

9.3

1435

12083

J34.2

ICD-10 Finland

Deviated nasal septum

1.6

9.3

221

1396

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.4

9.2

409

2924

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.5

9.2

243

1569

4760A

ICD-9 Finland

Chronic laryngitis and laryngotracheitis, Chronic laryngitis

12.1

9.2

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.3

9.2

584

4417

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.4

9.2

390

2767

SPAT1325

SPAT

Vaccination

1.2

9.2

1486

12563

J32.9

ICD-10 Finland

Chronic sinusitis, unspecified

2.5

9.2

211

M77.4

ICD-10 Finland

Metatarsalgia

1.5

9.2

268

1770

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.4

9.2

478

3511

XA800

NOMESCO Finland

Neuropsychological investigation

1.6

9.2

201

1245

B03XA01

ATC

erythropoietin; parenteral

3.8

9.1

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

9.1

1765

15175

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

1.9

9.1

106

547

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.3

9.1

609

4646

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.5

9.1

262

1727

H81.3

ICD-10 Finland

Other peripheral vertigo

2.1

9.1

413

4779A

ICD-9 Finland

Allergic rhinitis, Cause unspecified

3.1

9.0

114

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.4

9.0

412

2962

R52.2

ICD-10 Finland

Other chronic pain

1.7

9.0

146

835

TLC00

NOMESCO Finland

Insertion of intrauterine device

1.5

9.0

322

2217

0088X

ICD-9 Finland

Intestinal infections due to other organisms, Other organism, not elsewhere classified

2.3

9.0

286

J32

ICD-10 Finland

Chronic sinusitis

3.0

9.0

130

B01.9

ICD-10 Finland

Varicella without complication

2.8

9.0

146

Z01.9

ICD-10 Finland

Special examination, unspecified

1.6

9.0

223

1423

7580A

ICD-9 Finland

Chromosomal anomalies, Down's syndrome

36.2

8.9

OAA40, ,

SPAT

1.6

8.9

200

1245

M54.2

ICD-10 Finland

Cervicalgia

1.4

8.9

339

2359

Z02.7

ICD-10 Finland

Issue of medical certificate

1.4

8.9

352

2467

N02AC04

ATC

dextropropoxyphene; oral

2.2

8.9

325

R49

ICD-10 Finland

Voice disturbances

4.9

8.9

3811A

ICD-9 Finland

Nonsuppurative otitis media and Eustachian tube disorders, Chronic serous otitis media

4.9

8.9

L12

ICPC

Hand/finger symptom/complaint

1.3

8.9

937

7572

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.7

8.9

162

958

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.2

8.9

1090

8959

R4110, ,

SPAT

1.4

8.9

429

3115

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.7

8.8

147

847

C91.0

ICD-10 Finland

Acute lymphoblastic leukaemia [ALL]

4.5

8.8

WX402

NOMESCO Finland

General anaesthesia

1.2

8.8

1036

8471

D12

ICPC

Constipation

1.8

8.8

127

702

J35.1

ICD-10 Finland

Hypertrophy of tonsils

1.7

8.8

154

900

J30.4

ICD-10 Finland

Allergic rhinitis, unspecified

1.5

8.8

240

1563

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.4

8.8

337

2349

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.5

8.8

294

1997

J39.1

ICD-10 Finland

Other abscess of pharynx

7.3

8.8

K11.2

ICD-10 Finland

Sialoadenitis

1.8

8.8

133

746

A92

ICPC

Allergy/allergic reaction NOS

1.6

8.8

218

1390

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

1.8

8.8

122

667

N30.9

ICD-10 Finland

Cystitis, unspecified

1.5

8.8

253

1668

A08.0

ICD-10 Finland

Rotaviral enteritis

2.7

8.8

159

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

2.0

8.7

459

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.3

8.7

837

6687

ZXD20

NOMESCO Finland

Day surgery

1.3

8.7

492

3661

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

1.6

8.7

191

1184

SFA30

NOMESCO Finland

Three-surface restoration

1.2

8.7

1892

16428

S80.1

ICD-10 Finland

Contusion of other and unspecified parts of lower leg

1.7

8.7

157

926

GAE10

NOMESCO Finland

Closure of previous incision of chest wall

10.5

8.7

UGB02

NOMESCO Finland

Tracheoscopy

9.3

8.7

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

1.9

8.6

104

544

FDA00

NOMESCO Finland

Aortoplasty and aorto-pulmonary shunt for HLHS

49.3

8.6

R05DB20

ATC

other cough suppressants - combinations

1.5

8.6

248

1635

ZXC10

NOMESCO Finland

Use of laser

2.1

8.6

382

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.3

8.6

577

4404

N03AX11

ATC

topiramate; oral

1.8

8.6

119

651

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.3

8.6

634

4903

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.4

8.5

462

3414

J32.4

ICD-10 Finland

Chronic pansinusitis

2.5

8.5

213

E66

ICD-10 Finland

Obesity

1.5

8.5

289

1969

R62.0

ICD-10 Finland

Delayed milestone

2.3

8.5

274

N05BA12

ATC

alprazolam; oral

1.4

8.5

343

2414

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.6

8.5

195

1222

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.4

8.5

411

2985

UJF92

NOMESCO Finland

Capsular endoscopy

1.9

8.5

499

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.3

8.4

742

5865

ZY010

NOMESCO Finland

Hospital outpatient

1.4

8.4

339

2385

D07AC01

ATC

betamethasone; topical

1.2

8.4

1589

13617

SAB01

NOMESCO Finland

Restricted oral and dental health check by dental hygienist or dental assistant

1.3

8.4

666

5198

K80

ICPC

Cardiac arrhythmia NOS

1.5

8.4

272

1838

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.5

8.4

278

1887

GD1AD

NOMESCO Finland

Thorax CT examination

1.7

8.4

163

981

XF402

NOMESCO Finland

ECG with work load test

1.5

8.4

248

1645

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.7

8.4

151

891

N05CD08

ATC

midazolam; nasal, systemic

2.1

8.3

373

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

1.6

8.3

171

1043

S61.0

ICD-10 Finland

Open wound of finger(s) without damage to nail

1.3

8.3

525

3971

4740A

ICD-9 Finland

Chronic disease of tonsils and adenoids, Chronic tonsillitis

1.8

8.3

130

737

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

1.5

8.3

257

1720

H57.1

ICD-10 Finland

Ocular pain

1.6

8.3

194

1221

R75

ICPC

Sinusitis acute/chronic

1.5

8.3

212

1362

R81

ICPC

Pneumonia

1.8

8.3

127

716

127

Kela drug reimbursment

Transplant complication

2.3

8.3

253

B01AC04

ATC

clopidogrel; oral

1.4

8.3

300

2072

SPAT1240

SPAT

Therapeutic discussion

1.3

8.2

702

5527

K92.1

ICD-10 Finland

Melaena

1.7

8.2

149

880

H53.4

ICD-10 Finland

Visual field defects

2.2

8.2

291

N05AA02

ATC

levomepromazine; systemic

1.7

8.2

152

903

E000003, ,

ATC

1.6

8.2

192

1209

4931B

ICD-9 Finland

Asthma, Intrinsic asthma[INTRINSIC ASTHMA CUM EXACERBATIONE]

8.4

8.2

C32.0

ICD-10 Finland

Malignant neoplasm: Glottis

8.4

8.2

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.5

8.2

223

1453

M54

ICD-10 Finland

Dorsalgia

1.3

8.2

654

5109

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

1.7

8.2

133

763

XF404

NOMESCO Finland

Ambulatory ECG

1.5

8.1

246

1639

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.2

8.1

299

L13

ICPC

Hip symptom/complaint

1.3

8.1

604

4674

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.5

8.1

259

1745

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

1.8

8.1

105

563

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

2.2

8.1

306

SPAT1211

SPAT

Application of soft bandage

1.4

8.1

400

2917

L08

ICPC

Shoulder symptom/complaint

1.2

8.0

915

7454

L02

ICPC

Back symptom/complaint

1.3

8.0

571

4392

M01AH02

ATC

rofecoxib; oral

1.5

8.0

285

1961

P01BA02

ATC

hydroxychloroquine; oral

1.5

8.0

264

1790

EMB20

NOMESCO Finland

Adenotonsillectomy

1.7

8.0

134

775

Q20.48

ICD-10 Finland

Single ventricle

16.9

8.0

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

1.4

8.0

396

2887

J01EA01

ATC

trimethoprim; systemic

1.2

8.0

981

8056

N04BC05

ATC

pramipexole; oral

1.6

8.0

198

1264

LCA06

NOMESCO Finland

Biopsy of endometrium

1.4

8.0

385

2795

S43.4

ICD-10 Finland

Sprain and strain of shoulder joint

1.6

8.0

191

1210

R12

ICD-10 Finland

Heartburn

1.4

7.9

383

2780

1AB02, ,

NOMESCO Finland

21.7

7.9

XG466

NOMESCO Finland

Sleep oxymetry

2.0

7.9

441

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.4

7.9

355

2545

A02BA03

ATC

famotidine; systemic

2.0

7.9

374

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.5

7.9

225

1480

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

1.9

7.9

476

R83

ICPC

Respiratory infection other

1.2

7.9

1852

16161

TPH07

NOMESCO Finland

Cathetrisation of artery

1.4

7.9

317

2232

J35.8

ICD-10 Finland

Other chronic diseases of tonsils and adenoids

2.1

7.9

342

7862A

ICD-9 Finland

Symptoms involving respiratory system and other chest symptoms, Cough

3.9

7.9

TEW99

NOMESCO Finland

Other minor procedure in surgery of teeth, jaws, mouth and pharynx

1.6

7.9

191

1214

W10

ICD-10 Finland

Fall on and from stairs and steps

1.6

7.9

197

1261

NB1CG

NOMESCO Finland

Shoulder and humerus extensive MRI examination with high intensity magnet

2.0

7.8

382

RK110, ,

NOMESCO Finland

3.3

7.8

SFA20

NOMESCO Finland

Two-surface restoration

1.2

7.8

3408

31181

SPAT1202

SPAT

Intra-articular injection

2.1

7.8

323

78559

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD

2.0

7.8

376

XG460

NOMESCO Finland

Short time oxymetry

2.7

7.8

152

EBA15

NOMESCO Finland

Extraction of multiple teeth

1.7

7.8

125

715

M01AE01

ATC

ibuprofen; systemic, rectal

1.2

7.8

5445

51753

G04BD12

ATC

mirabegron; oral

1.5

7.8

269

1842

0799X

ICD-9 Finland

Viral and chlamydial infection in conditions classified elsewhere and of unspecified site, Unspecified viral and chlamydial infections

3.8

7.8

TGC00

NOMESCO Finland

Bronchial lavation

2.2

7.7

292

J02AC02

ATC

itraconazole; systemic

1.3

7.7

630

4931

E03.89

ICD-10 Finland

Other specified hypothyroidism

1.7

7.7

140

827

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.4

7.7

302

2114

EB1VA, ,

NOMESCO Finland

1.2

7.7

842

6823

A01AB10

ATC

natamycin; local oral

1.7

7.7

147

880

F51.0

ICD-10 Finland

Nonorganic insomnia

1.2

7.7

987

8137

H52.0

ICD-10 Finland

Hypermetropia

1.8

7.7

113

629

G44.1

ICD-10 Finland

Vascular headache, not elsewhere classified

3.2

7.7

Z63.7

ICD-10 Finland

Other stressful life events affecting family and household

1.7

7.7

121

688

XJC02

NOMESCO Finland

Mesurement of oesophageal pressure and pressure profile of lower oesophageal sphincter

4.6

7.7

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

2.4

7.7

218

SXC05

NOMESCO Finland

Other oral or dental procedure

1.3

7.7

474

3575

WX320

NOMESCO Finland

Spinalanesthesy

1.2

7.7

825

6678

F43.1

ICD-10 Finland

Post-traumatic stress disorder

1.6

7.6

184

1167

5410X

ICD-9 Finland

Appendicitis, unqualified[APPENDICITIS NUD]

3.5

7.6

OAA30, ,

SPAT

2.1

7.6

333

Z01.2

ICD-10 Finland

Dental examination

1.2

7.6

2939

26632

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.7

7.6

128

742

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.5

7.6

225

1495

P76

ICPC

Depressive disorder

1.3

7.6

449

3367

QBJ30

NOMESCO Finland

Correction of abdominal apron

2.6

7.5

155

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

1.6

7.5

190

1219

B27.0

ICD-10 Finland

Gammaherpesviral mononucleosis

2.0

7.5

355

WX734

NOMESCO Finland

JET-ventilation

7.9

7.5

M01AC01

ATC

piroxicam; systemic, rectal

1.4

7.5

313

2219

WX722

NOMESCO Finland

PEEP

1.7

7.5

123

709

M54.8

ICD-10 Finland

Other dorsalgia

1.5

7.4

196

1269

F83

ICD-10 Finland

Mixed specific developmental disorders

2.0

7.4

343

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.2

7.4

1032

8579

R51

ICD-10 Finland

Headache

1.4

7.4

321

2289

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.2

7.4

1219

10299

78050

ICD-8 Finland

Certain symptoms referable to nervous system and special senses, Vertigo

3.7

7.4

Z00.1

ICD-10 Finland

Routine child health examination

1.3

7.4

545

4210

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.4

7.4

271

1875

O99.89

ICD-10 Finland

Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium

1.7

7.4

116

659

N62

ICD-10 Finland

Hypertrophy of breast

1.6

7.4

170

1067

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

1.4

7.4

279

1942

EBA00

NOMESCO Finland

Extraction of tooth

1.2

7.4

2193

19473

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

1.5

7.4

218

1447

C03DA01

ATC

spironolactone; oral

1.4

7.4

299

2109

ZXC60

NOMESCO Finland

Application of heat

2.2

7.4

279

Y96.9

ICD-10 Finland

Unspecified type of accident

2.0

7.4

405

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.2

7.4

779

6292

K11.5

ICD-10 Finland

Sialolithiasis

2.2

7.3

254

N17.9

ICD-10 Finland

Acute renal failure, unspecified

1.8

7.3

510

K06.18

ICD-10 Finland

Another gingival hyperplasia

3.7

7.3

4931A

ICD-9 Finland

Asthma, Intrinsic asthma[INTRINSIC ASTHMA SINE EXACERBATIONE]

3.7

7.3

R56.0

ICD-10 Finland

Febrile convulsions

2.3

7.3

217

SPAT1097

SPAT

Recording of ECG

1.4

7.3

381

2802

XG405

NOMESCO Finland

Education on PEF monitoring

2.3

7.3

211

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

1.9

7.3

420

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

1.5

7.3

238

1612

Congenital heart failure surgery

4.2

7.3

TAB00

NOMESCO Finland

Lumbar puncture

1.5

7.3

190

1228

K50.0

ICD-10 Finland

Crohn disease of small intestine

2.0

7.2

387

ZX121

NOMESCO Finland

Central venous catheter

3.8

7.2

ND1BA

NOMESCO Finland

Wrist extensive X-ray examination

1.9

7.2

491

S69.9

ICD-10 Finland

Unspecified injury of wrist and hand

1.8

7.2

109

613

1450

FHL

Otomicroscopy

2.5

7.2

176

A02BA04

ATC

nizatidine; systemic

1.6

7.2

158

981

G04BD08

ATC

solifenacin; oral

1.7

7.2

139

836

S92.5

ICD-10 Finland

Fracture of other toe

1.6

7.2

147

898

R03AK

ATC

Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics

3.9

7.2

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.3

7.2

480

3663

SAA02

NOMESCO Finland

Basic examination of mouth

1.2

7.1

4550

42670

AA3AI

NOMESCO Finland

Cone beam CT of facial bones

2.3

7.1

207

R52.1

ICD-10 Finland

Chronic intractable pain

2.6

7.1

148

S97

ICPC

Chronic ulcer skin

1.6

7.1

155

961

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.3

7.1

427

3207

J13

ICD-10 Finland

Pneumonia due to Streptococcus pneumoniae

2.9

7.1

104

NH1BA

NOMESCO Finland

Ankle extensive X-ray examination

1.7

7.1

127

749

R23.3

ICD-10 Finland

Spontaneous ecchymoses

2.0

7.1

390

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

1.4

7.1

265

1843

WW200

NOMESCO Finland

Immunization

1.7

7.1

112

639

Q90

ICD-10 Finland

Down syndrome

19.7

7.1

Q21.21

ICD-10 Finland

Atrioventricular duct

19.7

7.1

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.4

7.1

359

2630

S90.3

ICD-10 Finland

Contusion of other and unspecified parts of foot

1.6

7.0

162

1018

R49.03

ICD-10 Finland

Atrophic dysphonia

3.3

7.0

XG431

NOMESCO Finland

Oscillometric spirometry with exercise provocation

4.2

7.0

-1, ,

NOMESCO Finland

1.2

7.0

2169

19297

F98.01

ICD-10 Finland

Non-organic diurnal enuresis

3.2

7.0

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.6

7.0

152

942

J37.1

ICD-10 Finland

Chronic laryngotracheitis

11.8

7.0

G50.1

ICD-10 Finland

Atypical facial pain

2.1

7.0

272

KH1AD

NOMESCO Finland

CT of urinary organs

1.7

7.0

120

700

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.7

7.0

130

775

D07AB08

ATC

desonide; topical

1.3

7.0

487

3736

A07EA06

ATC

budesonide; oral, local oral

1.6

7.0

172

1098

D70.89

ICD-10 Finland

Neutropenic splenomegaly

2.5

7.0

173

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.3

7.0

414

3105

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

1.5

7.0

205

1360

J06BA01

ATC

immunoglobulins, normal human, for extravascular adm.; systemic

8.6

7.0

L01

ICPC

Neck symptom/complaint

1.2

7.0

802

6538

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

2.6

6.9

150

K77

ICPC

Heart failure

2.6

6.9

150

RK220, ,

NOMESCO Finland

3.5

6.9

R01AC01

ATC

cromoglicic acid; nasal

1.5

6.9

209

1394

R4120

NOMESCO Finland

Occupational therapy

1.4

6.9

248

1711

D02AE01

ATC

carbamide; topical

1.4

6.9

256

1777

GX1L5

NOMESCO Finland

Exhaled nitric oxide analysis

2.4

6.9

174

WW200, ,

SPAT

1.2

6.9

1139

9623

C05AA01

ATC

hydrocortisone; rectal, topical

1.7

6.9

115

666

M16.1

ICD-10 Finland

Other primary coxarthrosis

1.5

6.9

234

1598

Z3231, ,

SPAT

3.7

6.9

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

2.2

6.9

261

7806A

ICD-9 Finland

General symptoms, Pyrexia of unknown origin

2.7

6.9

128

K04.08

ICD-10 Finland

Other specified pulpit

1.3

6.9

467

3570

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

1.7

6.9

111

637

R78

ICPC

Acute bronchitis/bronchiolitis

2.0

6.9

347

D07CC01

ATC

betamethasone and antibiotics; topical

1.3

6.9

485

3728

L01BA01

ATC

methotrexate; systemic

1.7

6.9

112

645

E000006, ,

ATC

1.4

6.8

251

1739

H02BX01

ATC

methylprednisolone, combinations; systemic

1.8

6.8

102

572

N92.0

ICD-10 Finland

Excessive and frequent menstruation with regular cycle

1.3

6.8

447

3399

Y89.9

ICD-10 Finland

Sequelae of unspecified external cause

2.5

6.8

163

R06.8

ICD-10 Finland

Other and unspecified abnormalities of breathing

2.0

6.8

375

3812A

ICD-9 Finland

Nonsuppurative otitis media and Eustachian tube disorders, Chronic mucoid otitis media

1.7

6.8

127

758

1220

FHL

Arthroscopy

1.7

6.8

105

595

H65.0

ICD-10 Finland

Acute serous otitis media

1.7

6.8

108

617

A34

ICPC

General and Unspecified, Blood test

2.1

6.8

295

P22.0

ICD-10 Finland

Respiratory distress syndrome of newborn

4.3

6.8

N89

ICPC

Migraine

1.4

6.7

276

1951

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

1.6

6.7

137

836

D09

ICPC

Nausea

1.4

6.7

341

2497

S89.9

ICD-10 Finland

Unspecified injury of lower leg

1.5

6.7

184

1203

J05AH02

ATC

oseltamivir; oral

2.6

6.7

141

L86

ICPC

Back syndrome with radiating pain

1.5

6.7

218

1476

ZX112

NOMESCO Finland

Subcutaneous

2.0

6.7

323

RL210, ,

NOMESCO Finland

3.9

6.7

H10

ICD-10 Finland

Conjunctivitis

1.3

6.7

452

3452

SPAT1262

SPAT

Handing over of treatment supplies

1.3

6.7

504

3906

J95.5

ICD-10 Finland

Postprocedural subglottic stenosis

39.4

6.7

FAE00

NOMESCO Finland

Anastomosis to pulmonary artery from superior vena cava

39.4

6.7

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

2.0

6.7

330

SPAT1229

SPAT

Assessment of need for aid

1.5

6.7

168

1078

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

1.5

6.7

178

1157

OAB42, ,

SPAT

1.2

6.7

755

6141

I20.09

ICD-10 Finland

Unstable angina

1.8

6.7

533

Y0399

ICD-8 Finland

Investigation of circulatory system

3.5

6.7

M77.1

ICD-10 Finland

Lateral epicondylitis

1.3

6.7

365

2705

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.3

6.7

391

2928

0086A

ICD-9 Finland

Intestinal infections due to other organisms, Enteritis due to specified virus[ENTERITIS VIROSA ROTA]

2.4

6.7

177

D07AD01

ATC

clobetasol; topical

1.3

6.7

613

4872

SPAT1382

SPAT

Extensive health check-up at 18 months of age

1.7

6.7

108

621

72870

ICD-8 Finland

Vertebrogenic pain syndrome, Lumbalgia

3.4

6.6

H65.2

ICD-10 Finland

Chronic serous otitis media

2.0

6.6

331

SPAT1255

SPAT

Intravenous administration of medicine

1.5

6.6

196

1302

B01AB04

ATC

dalteparin; parenteral

1.6

6.6

151

947

OAB93, ,

SPAT

1.3

6.6

422

3197

H65.9

ICD-10 Finland

Nonsuppurative otitis media, unspecified

2.0

6.6

365

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.4

6.6

271

1915

RK260, ,

NOMESCO Finland

7.0

6.6

M01AX01

ATC

nabumetone; oral

1.8

6.6

528

R25.1

ICD-10 Finland

Tremor, unspecified

1.8

6.6

485

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

1.9

6.6

380

WX704

NOMESCO Finland

Intubation

1.4

6.6

312

2262

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.4

6.6

316

2296

F43.00

ICD-10 Finland

Acute stress reaction mild

1.6

6.6

129

781

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

1.5

6.6

223

1524

TQW80

NOMESCO Finland

Local dermatologic skincare

1.8

6.6

500

R04

ICPC

Breathing problem other

1.6

6.6

144

896

S01GX02

ATC

levocabastine; ophthalmic

1.4

6.5

281

2005

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.6

6.5

128

775

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.2

6.5

1521

13231

J37

ICD-10 Finland

Chronic laryngitis and laryngotracheitis

12.0

6.5

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

2.0

6.5

327

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

2.1

6.5

274

SAA04

NOMESCO Finland

Special examination of mouth

1.4

6.5

306

2216

U07

ICPC

Urine symptom/complaint other

1.4

6.5

284

2032

RS221, ,

NOMESCO Finland

2.0

6.5

301

IGY99

NOMESCO Finland

Other psychiatric treatment contact

1.5

6.5

170

1103

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.3

6.4

360

2677

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

1.7

6.4

112

657

L16

ICPC

Ankle symptom/complaint

1.2

6.4

651

5231

DJD20

NOMESCO Finland

Plastic repair of septum of nose

1.6

6.4

133

816

F43.29

ICD-10 Finland

Adaptation disorder UNS

1.6

6.4

136

839

WX290

NOMESCO Finland

Other blockage of nerve

1.1

6.4

3170

29089

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

2.7

6.4

116

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

1.9

6.4

356

P01

ICPC

Feeling anxious/nervous/tense

1.2

6.4

1130

9600

K29.3

ICD-10 Finland

Chronic superficial gastritis

1.9

6.4

384

R03DX11

ATC

tezepelumab; systemic

68.8

6.4

S29

ICPC

Skin symptom/complaint other

1.2

6.4

908

7561

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

1.6

6.4

141

879

WZA10

NOMESCO Finland

Extensive medical or dental certificate

2.1

6.4

276

R52.0

ICD-10 Finland

Acute pain

1.6

6.4

150

949

N05CD02

ATC

nitrazepam; oral

2.5

6.4

145

JCA55

NOMESCO Finland

Endoscopic dilatation of oesophagus

3.1

6.4

R22.1

ICD-10 Finland

Localized swelling, mass and lump, neck

1.5

6.4

182

1202

N06AA10

ATC

nortriptyline; systemic

1.9

6.4

357

F03

ICPC

Eye discharge

1.3

6.3

354

2633

J33.0

ICD-10 Finland

Polyp of nasal cavity

1.8

6.3

456

C01AA05

ATC

digoxin; systemic

1.7

6.3

120

721

R33

ICD-10 Finland

Retention of urine

1.5

6.3

160

1030

R32

ICD-10 Finland

Unspecified urinary incontinence

1.9

6.3

386

N06AX22

ATC

agomelatine; oral

1.6

6.3

131

805

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

1.9

6.3

414

F50.2

ICD-10 Finland

Bulimia nervosa

2.2

6.3

232

JAH01

NOMESCO Finland

Laparoscopy

1.5

6.3

164

1062

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.4

6.3

227

1570

103

Kela drug reimbursment

Diabetes, insulin-treated

1.2

6.3

748

6118

M23.3

ICD-10 Finland

Other meniscus derangements

2.1

6.3

278

N06AX05

ATC

trazodone; oral

1.7

6.3

100

573

N93

ICPC

Carpal tunnel syndrome

2.2

6.3

239

H66

ICD-10 Finland

Suppurative and unspecified otitis media

1.5

6.3

171

1119

78330

ICD-8 Finland

Symptoms referable to respiratory system, Cough

10.8

6.2

7AX01, ,

NOMESCO Finland

10.8

6.2

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.4

6.2

215

1475

N06AB06

ATC

sertraline; oral

1.2

6.2

632

5081

46410, ,

ICD-8 Finland

+∞

6.2

4643A

ICD-9 Finland

Acute laryngitis and tracheitis, Acute epiglottitis

+∞

6.2

46104

ICD-8 Finland

Acute sinusitis, Pansinuitis

+∞

6.2

4618A

ICD-9 Finland

Acute sinusitis, Other acute sinusitis

+∞

6.2

7483C

ICD-9 Finland

Congenital anomalies of respiratory system, Other anomalies of larynx, trachea and bronchus[TRACHEOMALACIA]

+∞

6.2

H71

ICPC

Acute otitis media/myringitis

1.8

6.2

516

TPX10

NOMESCO Finland

Implantation of vascular injection port

1.7

6.2

538

50609

ICD-8 Finland

Chronic laryngitis, Unspecified

17.7

6.2

2AX04, ,

NOMESCO Finland

17.7

6.2

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

2.5

6.2

153

J42

ICD-10 Finland

Unspecified chronic bronchitis

2.6

6.2

124

E870A

ICD-9 Finland

Accidental cut, puncture, perforation or haemorrhage during medical care

2.9

6.2

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

2.9

6.2

FDF05

NOMESCO Finland

Percutaneous transluminal occlusion of aorto-pulmonary collaterals

26.3

6.2

Q39.11

ICD-10 Finland

Atresia of oesophagus with broncho-oesophageal fistula

26.3

6.2

J01.2

ICD-10 Finland

Acute ethmoidal sinusitis

26.3

6.2

C32.9

ICD-10 Finland

Malignant neoplasm: Larynx, unspecified

26.3

6.2

75930

ICD-8 Finland

Congenital syndromes affecting multiple systems, Down's disease

26.3

6.2

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

1.4

6.2

219

1510

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.5

6.2

201

1364

A10AB05

ATC

insulin aspart; parenteral

1.4

6.1

295

2144

S01GX08

ATC

ketotifen; ophthalmic

1.4

6.1

241

1693

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1.8

6.1

482

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

1.8

6.1

511

PD5AD

NOMESCO Finland

CT of aorta

2.1

6.1

274

A10AC01

ATC

insulin (human); parenteral

1.4

6.1

264

1885

J01DC04

ATC

cefaclor; oral

1.9

6.1

376

183

Kela drug reimbursment

Lamotrigin and topiramate

2.1

6.1

235

L84

ICD-10 Finland

Corns and callosities

1.7

6.1

112

667

K11.70

ICD-10 Finland

Hypoptyalism

3.3

6.1

SGA01

NOMESCO Finland

Emergency treatment

1.2

6.1

881

7347

F32

ICD-10 Finland

Depressive episode

1.4

6.1

324

2393

R69

ICD-10 Finland

Unknown and unspecified causes of morbidity

1.9

6.1

349

S62.3

ICD-10 Finland

Fracture of other metacarpal bone

1.6

6.1

149

952

G03DB01

ATC

dydrogesterone; oral

1.3

6.1

473

3683

WZC00, ,

SPAT

1.2

6.1

784

6465

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

1.6

6.1

147

937

SPAT1383

SPAT

Extensive health check-up at 4 years of age

1.6

6.1

147

937

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

1.5

6.1

187

1255

J35.3

ICD-10 Finland

Hypertrophy of tonsils with hypertrophy of adenoids

1.7

6.1

564

NB1BG, ,

SPAT

1.6

6.0

129

798

L50.8

ICD-10 Finland

Other urticaria

1.8

6.0

441

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

1.9

6.0

343

F71.1

ICD-10 Finland

Moderate mental retardation, significant impairment of behaviour requiring attention or treatment

7.5

6.0

K13.79

ICD-10 Finland

Change in the oral mucosa UNS

1.7

6.0

110

654

M02AA10

ATC

ketoprofen; topical

1.3

6.0

478

3731

1300

FHL

Esophagogastroduodenoscopy (also includes staining)

2.9

6.0

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

2.1

6.0

269

E87.6

ICD-10 Finland

Hypokalaemia

1.7

6.0

521

A77

ICPC

Viral disease other/NOS

1.5

6.0

198

1346

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.5

6.0

179

1193

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.5

6.0

191

1290

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1078

5461

2.13

99.83

2.0

1.7

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

805

3854

2.21

85.13

1.9

1.6

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

779

3739

2.19

81.68

2.0

1.6

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

2320

16472

1.60

66.05

2.0

1.7

—

(3023368) Bacteria identified in Blood by Culture

1495

9525

1.71

65.12

4.5

3.9

—

(3019198) Lymphocytes [#/volume] in Blood

3411

26892

1.52

58.26

7.6

6.2

2.02

2.00

e9/l

0.32

3073

23969

(3013115) Eosinophils [#/volume] in Blood

3412

26909

1.52

58.12

8.1

6.5

0.19

e9/l

1.69

3047

23779

(3013826) Glucose [Moles/volume] in Serum or Plasma

3309

25977

1.52

57.25

6.1

4.5

6.45

6.39

mmol/l

0.50

3086

23822

(3006315) Basophils [#/volume] in Blood

3307

26002

1.51

56.48

7.7

6.2

0.04

e9/l

0.12

2912

22644

(3001604) Monocytes [#/volume] in Blood

3304

25980

1.51

56.37

7.7

6.2

0.57

0.55

e9/l

5.45

2915

22637

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1950

13682

1.58

56.28

3.6

2.7

30.93

60.43

ng/l

0.95

1013

6830

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2650

19981

1.52

54.68

8.3

6.4

1.21

mmol/l

0.13

2334

17486

(3013650) Neutrophils [#/volume] in Blood by Automated count

3601

28954

1.50

54.27

10.3

8.9

4.06

3.93

e9/l

2.98

3181

25092

(3019069) Monocytes/Leukocytes in Blood

3065

23938

1.49

52.62

7.7

6.4

8.58

8.50

1.04

2910

22725

(3002030) Lymphocytes/Leukocytes in Blood

3174

25044

1.48

51.28

7.6

6.2

29.88

30.17

0.85

3046

24004

(3006504) Eosinophils/Leukocytes in Blood

3051

23885

1.49

51.27

7.7

6.3

2.84

2.82

0.19

2895

22653

(3018010) Neutrophils/Leukocytes in Blood

3128

24610

1.48

51.27

7.5

6.1

55.69

55.57

0.22

3019

23740

(3032080) INR in Blood by Coagulation assay

2203

16141

1.52

51.13

10.0

9.0

1.15

1.14

inr

0.04

1846

13319

(3022096) Basophils/Leukocytes in Blood

3046

23854

1.48

51.00

7.8

6.4

0.66

0.68

1.56

2889

22591

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1907

13557

1.54

50.85

2.8

2.5

52.92

64.34

u/l

1.26

1775

12625

(3007853) Bacteria identified in Skin by Aerobe culture

895

5264

1.78

50.46

2.0

1.6

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2366

17638

1.50

50.35

9.1

6.1

1.21

mmol/l

0.57

2215

16493

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1495

10188

1.58

47.54

2.3

1.8

0.90

1.05

mg/l

1.01

1101

7401

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2832

22166

1.46

45.75

6.0

5.6

11.07

11.53

umol/l

0.99

2669

20959

(3005322) IgE [Units/volume] in Serum or Plasma

690

3887

1.84

44.57

1.6

1.2

286.59

259.92

u/ml

0.23

652

3621

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

522

2708

1.98

43.32

6.7

3.7

5.10

5.13

kpa

0.51

500

2611

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

4214

35781

1.45

42.57

4.8

3.6

9.07

8.70

mm/h

1.38

4009

33855

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

4132

34956

1.45

42.57

8.1

6.8

77.39

76.79

u/l

0.42

3968

33280

(3009343) pH of Capillary blood

509

2652

1.96

41.67

6.8

3.7

7.41

0.40

432

2177

(3000850) Epithelial cells [#/volume] in Urine

1304

8922

1.55

39.76

3.0

2.4

6.67

6.66

e6/l

0.01

1204

8022

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

468

2414

1.98

39.40

7.0

3.7

1.23

1.27

mmol/l

0.11

331

1725

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

221

841

2.64

38.46

1.6

1.5

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

161

521

3.09

37.79

1.6

1.5

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

2347

18212

1.42

37.35

5.6

4.8

36.99

37.34

g/l

2.25

2232

17136

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

230

915

2.53

36.55

1.7

1.5

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

133

392

3.39

36.39

1.7

1.4

—

(3002582) Erythrocytes [#/volume] in Urine

1839

13728

1.44

35.90

3.8

2.8

57.20

61.70

e6/l

0.05

1420

10001

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

129

377

3.42

35.77

1.7

1.4

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1562

11354

1.47

34.91

2.3

2.1

208.74

248.46

u/l

0.90

1500

10841

(3048929) Epstein Barr virus Ab [Presence] in Serum

509

2819

1.84

34.43

1.4

1.3

—

(3031040) Bacteria [#/volume] in Urine by Automated count

3726

31563

1.38

33.84

4.9

3.7

282.23

1824.57

e6/l

3.96

388

(3021589) Normoblasts [#/volume] in Blood

2845

23110

1.38

33.33

11.7

9.2

0.00

e9/l

0.53

2373

18690

(3036481) Cortisol [Moles/volume] in Serum or Plasma

764

4786

1.65

33.31

2.3

2.0

366.01

386.12

nmol/l

2.19

713

4454

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2735

22094

1.38

33.07

2.9

2.4

71.92

71.97

nmol/l

0.03

2577

20827

(3007164) IgA [Mass/volume] in Serum or Plasma

1761

13202

1.43

33.05

1.6

1.4

2.08

2.16

g/l

1.36

1154

8533

(3005719) IgG [Mass/volume] in Serum or Plasma

638

3819

1.71

33.04

3.1

2.6

10.12

10.69

g/l

3.48

595

3540

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1137

7826

1.52

33.02

3.8

2.9

787.03

1006.13

ng/l

1.23

927

6304

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

170

615

2.77

32.68

1.4

1.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

170

615

2.77

32.68

1.4

1.2

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

5748

52834

1.62

32.43

16.2

10.5

20.89

21.56

mg/l

0.87

4803

40475

(3009261) Glucose [Presence] in Urine by Test strip

3222

26786

1.36

32.20

3.9

3.2

0.01

0.07

estimate

0.59

681

5189

(3012095) Magnesium [Moles/volume] in Serum or Plasma

962

6417

1.56

32.17

4.7

3.6

0.82

0.83

mmol/l

0.32

912

6091

(3035350) Ketones [Presence] in Urine by Test strip

3209

26674

1.36

32.04

3.9

3.2

5.32

3.81

estimate

0.16

697

5377

(3026008) Bacteria identified in Urine by Culture

1607

11916

1.43

31.82

3.0

2.5

—

(3029937) Albumin [Presence] in Urine by Test strip

1798

13607

1.42

31.76

4.0

3.3

0.00

estimate

0.00

667

5067

(3021601) Nitrite [Presence] in Urine by Test strip

3172

26358

1.36

31.53

3.9

3.2

0.00

estimate

1.60

697

5353

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

364

1859

1.98

31.43

1.8

1.5

—

(3022313) Gas panel - Capillary blood

377

1957

1.95

31.05

7.2

3.9

—

(3030467) Casts [#/volume] in Urine by Automated count

1598

11887

1.43

30.94

3.7

2.8

0.33

e6/l

0.01

1185

8244

(3028626) Oxygen [Partial pressure] in Capillary blood

298

1426

2.11

30.75

8.7

4.1

9.34

9.23

kpa

0.49

289

1386

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1590

11893

1.42

29.64

2.7

2.2

2.62

2.57

mg/l

0.39

1396

10348

(3037522) Nuclear Ab [Titer] in Serum

1059

7332

1.50

29.58

1.4

536.33

517.22

titre

0.12

196

1336

(36304419) Bacteria [Presence] in Urine

1559

11628

1.42

29.51

3.6

2.7

1.20

0.72

estimate

—

(3018095) Leukocytes [#/volume] in Urine

2174

17160

1.37

29.33

4.5

3.4

60.13

75.91

e6/l

0.60

1533

10964

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

508

2958

1.75

28.92

1.5

1.4

—

(3042936) Bacteria identified in Isolate by Culture

861

5731

1.55

28.83

2.1

1.9

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

333

1708

1.97

28.39

7.4

4.1

24.25

24.47

mmol/l

1.05

320

1638

(3023103) Potassium [Moles/volume] in Serum or Plasma

5460

49961

1.47

27.76

16.3

11.3

3.92

mmol/l

0.03

5334

48600

(3019550) Sodium [Moles/volume] in Serum or Plasma

5449

49843

1.47

27.73

16.3

11.2

139.57

139.63

mmol/l

1.58

5339

48616

(3003458) Phosphate [Moles/volume] in Serum or Plasma

799

5286

1.56

27.41

7.6

6.2

1.10

1.08

mmol/l

0.95

749

4962

(3015736) pH of Urine

2629

21570

1.34

26.83

3.4

2.9

6.23

0.08

1508

12098

(3018418) pH of Serum or Plasma

1527

11546

1.39

26.20

4.4

3.8

7.40

7.39

0.19

1063

7860

(3026782) Osmolality of Urine

1097

7828

1.46

26.00

3.1

2.5

536.20

548.79

mosm/kgh2o

0.96

982

6814

(44790047) Parainfluenza type 1 nucleic acid detection

135

489

2.75

25.96

1.7

1.4

—

(3022948) Iron [Moles/volume] in Serum or Plasma

997

6987

1.48

25.93

2.9

2.4

14.21

14.57

umol/l

0.72

951

6587

(40760892) CBC W Ordered Manual Differential panel - Blood

1669

12829

1.38

25.86

5.0

4.2

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

4648

41529

1.36

25.77

4.8

4.1

14.61

14.49

pmol/l

3.00

4355

38572

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

454

2650

1.74

25.57

1.8

1.6

—

(3048689) Calprotectin [Mass/mass] in Stool

1192

8663

1.43

25.56

3.2

2.8

115.72

120.26

ug/g

0.18

968

6959

(3023419) Bacteria identified in Sputum by Culture

285

3.31

25.38

4.3

2.1

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1139

8219

1.44

25.37

1.3

10.51

8.66

u/ml

0.39

459

3421

(3028026) IgM [Mass/volume] in Serum or Plasma

489

2928

1.70

25.10

2.1

1.8

1.21

1.29

g/l

0.81

456

2746

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

8.75

24.56

1.7

1.5

1.03

2.80

mg/l

0.71

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

8.75

24.56

1.7

1.5

2.91

3.38

mg/l

0.14

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

8.75

24.56

1.7

1.5

0.42

0.59

mg/l

0.23

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

8.75

24.56

1.7

1.5

1.57

0.76

mg/l

1.53

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

8.75

24.56

1.7

1.5

2.20

3.62

mg/l

0.51

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

8.75

24.56

1.7

1.5

0.75

1.64

mg/l

0.54

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

8.75

24.56

1.7

1.5

2.70

0.63

mg/l

0.71

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

8.75

24.56

1.7

1.5

1.36

0.94

mg/l

0.36

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

8.75

24.56

1.7

1.5

1.29

2.10

mg/l

0.37

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

284

1451

1.97

24.49

2.1

1.9

0.23

g/l

0.62

271

1398

(3024891) Influenza virus A+B Ag [Presence] in Specimen

310

1632

1.91

24.47

1.2

1.1

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

920

6414

1.48

24.44

2.9

2.4

2.50

2.44

g/l

2.22

873

5991

(44806118) Parainfluenza type 4 nucleic acid detection

132

489

2.69

24.33

1.7

1.4

—

(44790049) Parainfluenza type 3 nucleic acid detection

132

489

2.69

24.33

1.7

1.4

—

(44790048) Parainfluenza type 2 nucleic acid detection

132

489

2.69

24.33

1.7

1.4

—

(3002032) Base excess in Venous blood by calculation

618

3967

1.59

24.03

6.8

4.3

1.41

1.54

mmol/l

0.39

538

3375

(4062490) Immunoglobulin typing, IgG

129

476

2.70

23.97

1.4

1.3

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

8.28

23.52

1.7

1.5

1.32

2.16

mg/l

0.45

(3012544) pH of Venous blood

630

4092

1.57

23.26

6.7

4.3

7.37

0.14

368

2358

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

198

902

2.20

23.20

1.3

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

156

642

2.43

23.16

1.4

1.3

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

128

479

2.66

23.15

1.3

0.38

0.37

g/l

0.07

331

(3028192) IgG subclass 2 [Mass/volume] in Serum

128

479

2.66

23.15

1.3

2.98

2.99

g/l

0.02

332

(3027135) IgG subclass 1 [Mass/volume] in Serum

128

480

2.66

23.06

1.3

6.10

6.90

g/l

2.18

332

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

286

1496

1.92

23.02

2.1

1.8

1.22

1.18

g/l

1.36

272

1445

(3024354) Oxygen [Partial pressure] in Venous blood

549

3464

1.61

22.91

6.6

3.9

4.76

4.83

kpa

0.39

532

3361

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1222

9084

1.40

22.75

1.4

1.3

17.47

24.64

iu/ml

3.44

345

2498

(3021447) Carbon dioxide [Partial pressure] in Venous blood

624

4066

1.56

22.70

6.7

4.3

5.81

5.84

kpa

0.32

605

3949

(40758558) Short blood count panel - Blood

1786

14104

1.34

22.68

7.6

5.7

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

189

853

2.22

22.67

1.5

1.3

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

230

1121

2.06

22.64

5.6

2.5

24.57

24.39

mmol/l

0.33

225

1094

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1942

15533

1.33

22.57

1.5

1.4

1.73

1.83

u/ml

0.10

526

4341

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2450

20284

1.30

22.06

3.7

3.0

0.02

0.06

estimate

0.81

586

4481

(3015377) Calcium [Moles/volume] in Serum or Plasma

1770

14022

1.33

21.83

2.8

3.0

2.35

2.36

mmol/l

1.25

1643

13004

(3018677) aPTT in Platelet poor plasma by Coagulation assay

847

5935

1.47

21.76

3.0

2.4

29.75

29.36

1.44

831

5758

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2116

17201

1.31

21.72

3.5

3.2

29.98

31.25

u/l

0.75

2019

16369

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

7.19

21.58

1.4

1.2

1.12

1.65

iu/ml

1.00

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

830

5817

1.46

21.27

3.0

2.4

23.09

24.24

1.51

786

5476

(3000991) Gas panel - Venous blood

563

3639

1.57

21.18

13.3

9.1

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2157

17637

1.31

21.04

2.0

1.8

97.24

97.96

pmol/l

0.31

1199

9707

(3014111) Lactate [Moles/volume] in Serum or Plasma

530

3398

1.58

20.63

11.0

8.6

1.34

1.32

mmol/l

0.18

521

3343

(40768797) Stomach Pathology biopsy report

769

5360

1.47

20.22

1.3

1.2

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

101

361

2.78

20.01

3.0

2.3

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

3293

28573

1.27

19.65

3.7

3.1

85.75

84.78

ug/l

0.13

3128

27301

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

5243

48322

1.35

19.54

5.7

4.8

1.79

1.78

mu/l

0.23

5017

45963

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

992

7289

1.40

19.48

3.4

2.5

1.10

1.04

e6/l

0.13

531

3494

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

953

6955

1.41

19.46

4.0

3.1

205.36

463.23

ng/l

4.06

574

4249

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

182

862

2.11

19.38

2.8

2.4

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

325

1867

1.75

19.34

1.4

1.2

—

(3017732) Neutrophils [#/volume] in Blood

825

5880

1.44

19.22

3.1

2.9

4.57

4.36

e9/l

0.30

734

5284

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

108

410

2.62

19.06

1.4

1.2

1.89

5.78

u/ml

2.94

233

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

332

1945

1.72

18.43

1.7

1.5

—

(3019977) pH of Arterial blood

563

3755

1.52

18.32

11.0

8.6

7.42

7.41

2.32

316

1958

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

277

1547

1.80

18.16

1.2

1.1

5.01

4.33

0.52

277

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

935

6881

1.39

18.09

3.5

2.6

3.33

2.97

e6/l

0.46

475

3056

(3003396) Base excess in Arterial blood by calculation

558

3734

1.52

17.86

10.9

8.5

1.10

0.63

mmol/l

2.10

464

2998

(3030981) Hyaline casts [#/volume] in Urine by Automated count

458

2935

1.58

17.83

2.6

2.2

0.20

0.40

e6/l

2.64

433

2778

(3016502) Oxygen saturation in Arterial blood

499

3265

1.55

17.72

11.6

9.2

96.11

96.14

0.04

482

3150

(3021960) Folate [Moles/volume] in Serum or Plasma

1365

10686

1.33

17.67

1.7

1.6

19.59

19.65

nmol/l

0.05

1208

9488

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

202

1030

1.96

17.59

1.9

2.0

1.15

2.02

ug/l

1.33

177

921

(3000494) Fungus identified in Specimen by Culture

798

5749

1.42

17.42

1.5

1.4

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

557

3746

1.51

17.40

11.0

8.6

5.08

5.09

kpa

0.13

538

3599

(3026493) Urate [Moles/volume] in Serum or Plasma

1328

10383

1.33

17.30

2.6

2.3

331.86

328.82

umol/l

0.54

1208

9567

(3027801) Oxygen [Partial pressure] in Arterial blood

556

3746

1.50

17.22

11.0

8.6

13.04

13.57

kpa

1.36

540

3599

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

117

491

2.37

16.74

1.4

1.3

—

(3020779) Urea [Moles/volume] in Serum or Plasma

502

3333

1.52

16.66

10.0

7.8

7.45

7.71

mmol/l

0.47

486

3213

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

5.70

16.27

2.6

2.2

179.47

160.40

ug/g

0.21

(3017181) Myelocytes/Leukocytes in Blood

562

3849

1.48

16.03

5.1

4.8

0.68

0.92

1.07

166

1002

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

282

1642

1.72

16.03

9.7

5.2

1.25

1.24

mg/l

0.06

273

1545

(3047007) Chlamydophila sp Ab [Presence] in Serum

179

906

1.97

15.96

1.2

—

(1175426) CD3 cells/Lymphocytes in Blood

395

2.49

15.84

3.0

2.3

71.51

72.84

0.28

383

(3052851) Hemolysis interference index of Serum or Plasma

200

1054

1.90

15.82

3.0

2.6

2.30

2.93

index

0.42

115

534

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

372

2.54

15.81

1.3

1.5

—

(3021440) Promyelocytes/Leukocytes in Blood

543

3704

1.48

15.80

5.2

4.9

0.04

0.11

3.17

150

858

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

151

728

2.07

15.42

1.5

1.3

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

168

842

1.99

15.42

1.1

1.48

2.40

1.11

177

(3044640) Blood type and Crossmatch panel - Blood

1810

14924

1.27

15.41

2.7

2.1

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

586

4080

1.45

15.35

5.3

4.8

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

289

1715

1.69

15.33

1.5

4.00

10.93

iu/ml

2.11

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2607

22430

1.24

15.22

3.1

2.6

—

estimate

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

565

3918

1.46

15.11

3.0

2.6

0.22

0.23

g/l

0.64

532

3654

(3011412) CD3 cells [#/volume] in Blood

109

465

2.33

15.07

3.1

2.6

1312.37

1320.02

e6/l

0.03

376

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

323

2.61

15.06

1.4

1.5

—

(3022145) Colonoscopy Study observation

673

4829

1.41

14.94

1.4

1.5

—

(3002179) Metamyelocytes/Leukocytes in Blood

535

3679

1.47

14.93

4.9

4.5

0.50

0.65

0.86

158

961

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

256

1492

1.72

14.53

1.3

—

(3027945) Reticulocytes/Erythrocytes in Blood

568

3978

1.44

14.40

4.0

2.8

1.69

0.02

520

3621

(3020564) Creatinine [Moles/volume] in Serum or Plasma

5873

55627

1.41

14.36

17.1

12.3

72.62

72.24

umol/l

0.47

5812

54959

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

232

1320

1.76

14.34

2.1

1.8

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

168

864

1.94

14.34

1.5

1.8

0.66

0.80

g/l

1.28

125

682

(3023520) Reticulocytes [#/volume] in Blood

426

2820

1.52

14.32

3.5

2.7

71.40

70.86

e9/l

0.10

308

1928

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

5107

47465

1.28

13.93

13.0

9.7

94.97

94.83

ml/min/173m2

0.18

4624

41990

(1616796) Gas panel - Central venous blood

159

812

1.95

13.87

4.2

3.2

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

459

3114

1.49

13.71

11.7

9.4

124.49

123.77

g/l

0.29

449

3039

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

186

1012

1.83

13.38

1.7

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

6.39

13.35

1.6

1.1

0.13

0.98

iu/ml

1.39

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

332

2119

1.57

13.17

1.2

1.1

3.53

2.89

u/ml

0.39

193

1181

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

4991

46372

1.26

12.95

4.0

3.7

5.67

5.64

mmol/l

0.95

4729

43669

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

566

4038

1.42

12.94

4.4

231.59

240.03

u/l

0.76

542

3861

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

207

1177

1.76

12.86

2.1

1.7

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

499

3486

1.44

12.81

3.7

3.5

4.65

4.70

pmol/l

0.47

448

3186

(3041096) Erythrocytes [Presence] in Urine by Automated

1847

15562

1.23

12.45

3.2

2.6

0.03

0.12

estimate

0.86

588

4363

(3006245) CD3-CD19+ cells/cells in Blood

278

2.57

12.42

3.5

2.5

15.37

10.00

1.63

268

(3025159) Blasts/Leukocytes in Blood

535

3809

1.42

12.37

5.6

5.0

0.11

0.35

0.77

133

828

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

700

5212

1.36

12.36

3.3

2.8

6.02

7.18

umol/l

2.01

609

4521

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

342

2232

1.54

12.30

2.4

2.0

3.94

7.48

ug/l

6.49

296

1966

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

240

2.68

12.26

1.4

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

240

2.68

12.26

1.4

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

240

2.68

12.26

1.4

1.5

—

(3019150) Specific gravity of Urine by Refractometry

1483

12216

1.25

12.24

3.8

3.1

1.02

1.42

kg/l

1.08

949

7511

(3020961) Endomysium IgA Ab [Titer] in Serum

486

3413

1.43

12.12

1.2

48.50

170.71

titre

—

119

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

323

2089

1.55

12.11

3.6

2.8

132.05

141.83

ng/l

0.19

289

1840

(3013005) Retinol [Moles/volume] in Serum or Plasma

292

2.48

11.73

2.8

2.3

1.93

1.81

umol/l

0.53

268

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

371

2.30

11.69

3.5

2.6

526.13

528.74

e6/l

0.02

274

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

5867

55817

1.36

11.62

11.4

8.9

28.43

27.62

u/l

1.31

5761

54538

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

101

469

2.14

11.49

1.1

6.00

6.85

iu/ml

0.18

127

(3051611) Lipemic interference index of Serum or Plasma

332

2.36

11.41

3.4

3.0

15.63

14.24

index

0.40

218

(3044889) 12 lead EKG panel

3421

30778

1.20

11.41

3.5

3.0

0.20

12876.38

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

198

1152

1.71

11.38

1.1

27.23

15.89

au/ml

0.42

348

(3000060) B lymphocytes [#/volume] in Blood

228

2.65

11.27

3.6

2.3

0.28

0.21

e9/l

0.57

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

297

1917

1.55

11.25

2.2

2.1

41.52

40.29

u/l

0.44

276

1786

(3016244) Insulin [Units/volume] in Serum or Plasma

113

553

2.03

11.20

2.8

3.0

25.02

27.41

mu/l

0.18

103

523

(3023420) DNA double strand Ab [Units/volume] in Serum

320

2102

1.52

11.19

2.0

1.9

8.76

6.18

iu/ml

0.62

523

(3003129) Base excess in Capillary blood by calculation

318

2.37

11.09

2.2

1.8

0.79

0.58

mmol/l

0.22

300

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

114

3.38

11.05

1.0

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

114

3.38

11.05

1.0

1.4

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

199

1170

1.70

11.02

1.4

1.3

—

(3009508) Creatinine [Moles/volume] in Urine

1710

14441

1.22

11.02

3.8

3.4

8.47

8.60

mmol/l

0.38

1507

12881

(3025941) Bacteria identified in Stool by Culture

442

3105

1.43

11.01

1.2

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

375

2.25

10.99

3.5

2.7

202.13

231.60

e6/l

0.72

289

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

394

2717

1.45

10.84

5.5

4.1

78.85

78.18

ng/l

0.04

355

2450

(3043409) Potassium [Moles/volume] in Arterial blood

141

753

1.86

10.84

7.1

3.7

3.84

3.85

mmol/l

0.04

141

744

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

156

2.98

10.82

1.6

1.3

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

4818

44855

1.22

10.82

5.0

4.5

37.46

37.16

mmol/mol

1.46

4594

42966

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

147

796

1.84

10.81

5.0

3.0

622.21

483.64

u/ml

0.18

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

211

2.67

10.75

1.6

1.3

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

451

2.11

10.63

1.2

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

500

3615

1.39

10.57

2.3

11.85

18.92

au/ml

4.06

505

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

308

2035

1.51

10.50

14.5

11.1

24.26

24.05

mmol/l

0.49

300

1996

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

159

2.92

10.48

1.0

1.3

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

285

1858

1.53

10.34

4.6

3.9

1.31

1.30

0.07

285

1847

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

5.18

10.34

4.8

4.4

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

289

1892

1.53

10.29

1.2

1.1

5.62

7.18

u/ml

0.96

181

1152

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

177

2.79

10.28

1.4

1.2

0.31

0.29

g/l

0.49

139

(3020393) Adenovirus Ag [Presence] in Stool

3.73

10.19

1.9

1.4

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

176

1024

1.71

10.16

6.1

5.0

672.76

628.83

iu/ml

0.04

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

162

2.87

10.15

1.0

1.3

—

(3045414) Leukocytes [Presence] in Urine

531

3904

1.37

10.13

1.9

0.00

0.04

estimate

3.50

123

975

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

596

4464

1.35

10.08

2.8

2.5

42.62

37.43

u/l

0.39

517

3823

(3008401) Mugwort IgE Ab [Units/volume] in Serum

277

1807

1.53

10.03

1.2

1.1

0.88

1.45

u/ml

1.29

138

917

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

281

1844

1.52

9.91

4.7

3.9

0.65

0.62

1.00

281

1836

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

265

1717

1.54

9.90

3.9

3.0

3.53

3.49

g/l

0.21

256

1634

(3012501) Base excess in Blood by calculation

139

763

1.81

9.82

3.8

3.7

2.21

2.10

mmol/l

0.21

477

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1360

11343

1.23

9.71

2.7

2.1

—

(3020630) Protein [Mass/volume] in Serum or Plasma

349

2403

1.45

9.70

2.0

2.5

66.13

67.27

g/l

2.11

326

2266

(3036489) Thrombin time

297

1981

1.50

9.70

3.4

2.5

20.34

20.74

0.98

263

1718

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

5066

47566

1.22

9.62

18.2

13.3

13.31

13.24

4.75

5000

46861

(3014051) Protein [Presence] in Urine by Test strip

1801

15465

1.20

9.52

2.8

2.5

0.06

0.05

0.06

210

(40768804) Tissue Pathology biopsy report

2062

17962

1.19

9.24

2.0

1.9

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

149

2.85

9.23

1.6

1.3

—

(3033658) Prothrombin time (PT) actual/Normal

1378

11562

1.22

9.22

5.2

3.8

93.45

93.20

0.15

1350

11309

(3015171) Extractable nuclear Ab [Units/volume] in Serum

281

1875

1.50

9.17

1.3

0.35

0.58

u/ml

0.52

120

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

631

4831

1.32

9.17

2.5

2.4

6392.34

6479.95

u/l

0.02

236

1856

(3008152) Bicarbonate [Moles/volume] in Arterial blood

280

1869

1.50

9.13

9.1

6.4

24.67

24.28

mmol/l

0.95

271

1772

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

191

1175

1.62

8.95

1.6

1.4

5.40

6.03

iu/ml

—

(3035933) Granulocytes/Leukocytes in Blood

189

1160

1.62

8.94

3.5

3.1

55.54

57.27

1.07

189

1160

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

458

3370

1.36

8.70

1.2

1.3

24.01

46.75

au/ml

4.12

202

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

236

1536

1.53

8.69

4.6

3.7

52.92

48.91

1.59

230

1506

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

203

1279

1.58

8.63

2.4

214.92

593.86

ug/l

1.20

191

1185

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

250

1651

1.51

8.60

2.3

2.2

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

430

2.00

8.50

1.4

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

119

653

1.81

8.48

1.2

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

274

1851

1.48

8.44

1.2

1.1

2.63

2.54

u/ml

0.05

162

1023

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

390

2815

1.39

8.35

4.3

3.5

1.22

1.23

mmol/l

1.74

331

2419

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

125

700

1.77

8.33

1.7

1.6

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

233

1528

1.52

8.30

1.5

1.3

223.02

227.69

u/ml

0.09

146

929

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

434

1.99

8.29

7.1

6.6

10.06

10.57

mg/l

0.51

407

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

249

1659

1.50

8.22

4.0

2.9

166.74

173.14

0.59

242

1586

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

443

1.97

8.18

1.4

1.3

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

241

1599

1.50

8.13

1.1

5.79

4.93

u/ml

0.28

147

879

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

199

1267

1.56

8.11

1.7

1.5

130.74

137.04

au/ml

0.31

355

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

105

563

1.85

8.08

1.1

22.88

17.67

u/ml

0.56

249

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

419

1.99

8.02

1.4

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

680

5353

1.28

7.99

2.6

2.2

12.73

13.10

nmol/l

0.56

625

4973

(3005988) Vibrio sp identified in Specimen by Organism specific culture

420

1.98

7.97

1.4

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

173

2.57

7.97

1.6

1.3

—

(40761536) Microorganisms panel - Urine sediment

536

4091

1.32

7.96

3.9

3.1

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

434

1.96

7.95

1.4

—

(3035941) MCH [Entitic mass]

6238

60313

1.45

7.89

22.9

16.2

29.96

29.99

0.73

6201

59802

(3024731) MCV [Entitic mean volume] in Red Blood Cells

6237

60306

1.45

7.84

22.9

16.2

89.42

89.52

1.05

6200

59795

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

491

3713

1.33

7.79

3.2

2.8

—

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

6238

60323

1.45

7.77

23.6

16.6

41.80

41.92

0.05

6198

59783

(3026361) Erythrocytes [#/volume] in Blood

6238

60326

1.45

7.74

23.0

16.2

4.62

e12/l

0.18

6135

58950

(3007461) Platelets [#/volume] in Blood

6234

60282

1.44

7.72

23.1

16.3

261.99

258.60

e9/l

4.17

6136

59026

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

205

1330

1.53

7.70

1.7

1.4

—

(36660697) Celiac disease serology panel - Serum

687

5442

1.27

7.67

1.2

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

143

854

1.66

7.60

6.9

5.9

379.72

377.75

umol/l

0.05

129

762

(3023183) Ammonium ion [Moles/volume] in Plasma

141

839

1.67

7.60

3.6

2.9

36.94

34.10

umol/l

0.64

133

778

(3010813) Leukocytes [#/volume] in Blood

6239

60350

1.44

7.59

23.0

16.3

6.82

6.65

e9/l

6.45

6137

58948

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

619

4848

1.28

7.57

1.3

1.2

147.80

148.72

u/ml

0.01

244

1831

(3000570) Elastase.pancreatic [Mass/mass] in Stool

174

1092

1.58

7.57

1.4

298.20

294.35

ug/g

0.08

588

(3009214) Lutropin [Units/volume] in Serum or Plasma

408

3017

1.35

7.54

1.8

1.6

7.35

7.81

u/l

0.42

332

2339

(3019225) pH of Specimen

425

3165

1.34

7.49

3.7

3.4

7.34

7.35

0.50

293

2302

(3025468) Yersinia sp identified in Specimen by Organism specific culture

416

1.95

7.49

1.4

—

(3019309) Folate [Moles/volume] in Red Blood Cells

676

5362

1.27

7.46

1.7

1115.49

1149.11

nmol/l

0.48

512

4162

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

104

572

1.80

7.41

1.8

1.4

—

(3008898) HLA-B27 [Presence]

355

2575

1.38

7.41

1.1

—

(3000963) Hemoglobin [Mass/volume] in Blood

6238

60357

1.44

7.38

23.2

16.4

137.72

138.00

g/l

0.86

6201

59857

(3020682) Albumin/Creatinine [Ratio] in Urine

1257

10663

1.20

7.31

4.4

4.3

7.75

9.10

mg/mmol

0.49

802

7037

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

871

7126

1.23

7.31

2.3

2.6

2.42

mmol/l

0.15

792

6358

(3012516) Albumin [Mass/volume] in Urine

1239

10499

1.20

7.29

3.7

3.6

68.17

55.58

mg/l

0.31

800

6962

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

108

604

1.77

7.29

1.2

1.3

—

12.83

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

312

2223

1.40

7.25

4.1

3.9

131.72

132.96

g/l

0.42

300

2172

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

265

1834

1.44

7.25

4.0

2.8

94.21

95.41

0.41

258

1766

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

139

835

1.65

7.24

5.9

4.3

0.32

0.33

iu/ml

0.20

407

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

967

8009

1.22

7.21

1.6

39094612.22

29001577.14

pmol/l

0.18

839

6948

(3006184) Hemoglobin [Mass/volume] in Capillary blood

147

897

1.63

7.20

2.4

2.0

133.12

133.80

g/l

0.15

121

732

(3023430) Cat dander IgE Ab [Units/volume] in Serum

223

1495

1.48

7.19

1.1

5.66

7.16

u/ml

0.60

124

733

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

192

2.37

6.90

1.6

1.5

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

280

1976

1.41

6.90

12.9

10.9

16.41

16.33

0.15

271

1898

(3003740) Influenza virus B Ag [Presence] in Specimen

229

1558

1.46

6.87

1.2

1.1

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

5279

50156

1.19

6.87

4.2

3.9

4.63

4.69

mmol/l

4.09

5077

48215

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

235

1607

1.46

6.87

1.4

1.3

41.92

41.04

u/ml

—

(3002523) Influenza virus A Ag [Presence] in Specimen

229

1559

1.46

6.85

1.2

1.1

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

112

645

1.72

6.85

1.3

1.2

94.29

376.96

titre

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

203

1350

1.50

6.83

1.2

1.3

2.98

3.89

u/ml

0.27

120

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

169

2.46

6.82

1.0

26.57

35.64

iu/ml

0.69

169

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

407

3056

1.33

6.81

3.0

2.4

75.96

78.59

ml/min/173m2

0.57

162

1216

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

147

917

1.59

6.62

1.5

1.9

10.03

10.54

g/l

0.85

134

842

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

123

734

1.66

6.61

1.1

1.2

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

214

1450

1.47

6.58

1.2

1.3

26.53

34.77

u/ml

0.25

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

198

1321

1.49

6.57

1.1

0.24

0.56

u/ml

0.91

426

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

205

1378

1.48

6.56

1.9

1.4

455.75

480.87

mg/l

0.31

196

1326

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

201

1346

1.48

6.55

1.2

1.3

3.51

12.55

u/ml

3.01

189

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

4948

46815

1.17

6.51

3.6

3.3

1.26

1.25

mmol/l

0.82

4730

44678

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

204

2.28

6.48

1.2

1.1

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

4239

39672

1.15

6.40

3.6

3.0

39.11

37.63

u/l

0.67

4077

38161

(3027273) Bicarbonate [Moles/volume] in Venous blood

206

1396

1.47

6.34

4.0

3.3

25.03

25.18

mmol/l

0.28

196

1337

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

126

766

1.63

6.32

1.7

1.9

0.00

g/l

-0.00

109

687

(3042631) Mycobacterium sp identified in Specimen

297

2.03

6.32

3.7

2.2

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

184

1220

1.50

6.31

1.9

1.3

3.64

3.58

mmol/l

0.27

164

1156

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

5245

49905

1.18

6.23

4.1

3.8

1.40

1.43

mmol/l

5.52

5032

47801

(3044290) Cell count panel - Cerebral spinal fluid

173

1139

1.51

6.15

2.1

1.5

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

355

1.92

6.13

1.3

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

3.12

6.10

6.9

3.8

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

163

1064

1.52

6.04

1.2

1.3

1.03

2.59

u/ml

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

178

1189

1.49

5.92

2.3

11.21

10.93

mg/l

0.19

169

1142

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

221

1539

1.43

5.92

2.2

2.72

7.04

iu/l

0.71

105

701

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

278

2.03

5.90

1.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

353

1.91

5.89

4.2

3.1

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

267

2.04

5.77

1.3

1.6

1.94

3.45

nmol/l

0.83

213

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

5288

50423

1.17

5.76

4.5

4.2

2.80

2.82

mmol/l

1.21

5063

48248

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

441

1.80

5.75

1.8

1.5

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

213

1484

1.43

5.70

1.8

2.0

1.53

1.36

g/l

1.45

188

1302

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

129

811

1.58

5.68

1.7

1.9

0.00

0.02

g/l

1.44

117

747

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

210

2.16

5.66

1.1

100.72

93.30

0.86

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

6.00

5.60

6.1

4.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

309

2297

1.34

5.59

1.4

1.3

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

541

1.70

5.57

1.3

1.2

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

142

919

1.53

5.51

2.0

0.46

0.85

g/l

1.09

125

818

(44816559) Phosphatidylethanol [Mass/volume] in Blood

400

3089

1.29

5.51

1.9

1.8

0.26

0.28

mg/l

0.21

191

1431

(3017143) Hepatitis C virus Ab [Presence] in Serum

1158

9976

1.17

5.51

1.7

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

132

2.47

5.49

1.2

71.86

79.77

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

200

2.17

5.49

1.2

94.29

94.27

0.00

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

314

1.92

5.45

1.2

1.1

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

116

720

1.60

5.41

1.6

1.9

0.00

g/l

-0.00

109

686

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

551

4434

1.24

5.39

3.9

3.7

31.18

31.64

0.51

415

3289

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

159

1060

1.49

5.38

1.6

1.9

7.32

7.27

g/l

0.13

147

990

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

158

1052

1.49

5.37

1.1

2.54

3.32

eliau/ml

0.58

551

(1002224) Polysomnography panel

411

3199

1.28

5.33

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

380

1.82

5.32

1.4

1.1

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

135

2.41

5.25

1.2

71.83

91.61

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

178

1220

1.45

5.24

2.2

1.5

22.09

31.02

e6/l

0.26

135

869

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

158

1058

1.48

5.24

1.6

1.9

3.89

3.73

g/l

0.63

146

989

(4015189) Microbial culture of sputum

3.67

5.22

2.9

2.6

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

180

1237

1.44

5.22

2.2

1.5

175.34

4033.20

e6/l

0.65

143

939

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

158

1060

1.48

5.19

1.6

1.9

4.34

4.24

g/l

0.50

147

990

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2142

19350

1.13

5.18

1.8

1.42

1.38

mmol/l

1.11

1872

17242

(3023323) Follitropin [Units/volume] in Serum or Plasma

545

4401

1.24

5.17

1.6

1.5

16.25

18.93

iu/l

1.57

448

3593

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

377

1.81

5.15

1.4

1.1

—

(3045424) Erythrocytes [Presence] in Urine

275

2037

1.34

5.12

1.9

0.00

0.03

estimate

3.05

100

772

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

187

2.17

5.09

1.2

1.5

13.53

14.01

pmol/l

0.36

158

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

484

1.70

4.97

1.1

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

150

1007

1.48

4.93

1.6

2.0

2.91

2.93

g/l

0.13

138

937

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

508

4094

1.24

4.92

1.1

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

250

1.98

4.90

1.2

22.45

9.91

u/ml

0.58

176

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

6.78

4.88

9.7

4.9

—

(3026389) Candida sp identified in Specimen by Organism specific culture

116

739

1.55

4.88

1.5

1.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

275

2054

1.33

4.86

1.5

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

335

1.83

4.82

3.8

3.1

161.66

126.20

au/ml

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

141

2.31

4.80

1.5

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

141

2.31

4.80

1.5

1.6

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

141

2.31

4.80

1.5

1.6

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

141

2.31

4.80

1.5

1.6

—

(3004809) Band form neutrophils/Leukocytes in Blood

528

1.65

4.75

4.1

2.8

1.07

1.41

0.51

481

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

267

1.92

4.73

1.1

5.74

4.19

nmol/l

0.12

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1732

15514

1.13

4.70

2.5

2.4

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

414

3279

1.26

4.69

2.0

1.9

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

515

1.65

4.68

1.6

1.3

68.60

75.13

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

275

1.90

4.68

2.5

3.0

96.13

173.85

umol/l

1.51

139

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

262

1.92

4.64

4.6

3.6

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

247

1830

1.34

4.63

1.9

1.8

197.27

211.13

pmol/l

1.21

236

1765

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1609

14357

1.14

4.63

2.4

2.3

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

400

1.73

4.54

1.1

1.3

1.94

1.85

mmol/l

0.32

375

(3003327) Ova and parasites identified in Stool by Light microscopy

320

2466

1.29

4.53

1.7

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

190

2.08

4.52

1.1

1.4

86.15

242.58

nmol/24h

0.55

190

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

3.29

4.47

1.1

1.0

108.00

98.67

titre

0.18

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

113

731

1.53

4.47

1.2

2.00

0.78

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

166

1161

1.42

4.44

1.2

50.26

51.36

u/ml

0.03

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

232

1.96

4.43

2.2

1.6

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

272

2058

1.31

4.42

1.7

5.76

11.41

u/ml

3.15

634

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

212

2.00

4.41

1.3

1.2

—

(3047181) Lactate [Moles/volume] in Blood

153

1057

1.43

4.38

4.1

5.6

1.26

1.25

mmol/l

0.06

130

915

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

383

1.73

4.36

1.3

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

248

1.91

4.32

1.2

1.1

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

107

690

1.54

4.31

2.3

1.4

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

604

1.57

4.31

1.2

81.43

24.24

u/l

0.93

518

(3018851) Theophylline [Moles/volume] in Serum or Plasma

7.39

4.30

3.1

1.9

44.33

50.92

umol/l

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

267

2024

1.31

4.29

1.5

1.6

0.21

0.18

iu/ml

0.08

325

(3011985) Renin [Units/volume] in Plasma

628

1.56

4.29

1.8

1.6

83.08

75.93

mu/l

0.12

565

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

505

1.63

4.28

1.2

1.3

0.18

0.20

nmol/l

0.27

391

(44813793) Dust mix specific IgE antibody measurement

440

1.66

4.18

1.1

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1708

15395

1.12

4.11

1.8

—

(40768443) Skin Pathology biopsy report

245

1855

1.31

4.00

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

134

2.21

3.99

1.1

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

134

2.21

3.99

1.1

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

134

2.21

3.99

1.1

1.0

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.44

3.98

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

222

1.91

3.91

1.1

1.0

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

422

3423

1.23

3.90

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

188

1376

1.36

3.88

1.1

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

240

1821

1.31

3.87

1.1

3.94

5.07

eliau/ml

0.29

287

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

382

1.68

3.87

5.4

4.0

7.72

9.32

mg/l

1.32

306

(3022621) pH of Urine by Test strip

450

3679

1.22

3.85

2.3

2.1

6.11

6.18

0.94

268

2225

(3004616) Nuclear Ab [Presence] in Serum

507

1.58

3.77

1.3

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

154

1098

1.39

3.75

1.4

15.01

18.88

u/l

1.08

136

923

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

610

1.52

3.74

1.2

1.3

1.25

0.29

nmol/l

—

(3010838) Calcium [Moles/time] in 24 hour Urine

108

722

1.48

3.73

2.1

5.37

5.32

mmol/24h

0.04

100

666

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

187

1378

1.35

3.71

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

179

1.98

3.66

1.2

1.1

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

2.69

3.63

1.2

1.1

4.13

4.05

u/ml

0.01

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

2.36

3.59

1.8

2.7

12.11

31.19

mg/l

—

(3040893) Potassium [Moles/volume] in Capillary blood

7.66

3.52

7.9

1.4

4.20

4.26

mmol/l

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.38

3.50

1.5

1.4

—

(3003694) ABO and Rh group [Type] in Blood

1970

18038

1.11

3.47

1.7

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

176

1.96

3.47

1.3

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

186

1385

1.33

3.47

1.1

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

2147

19751

1.10

3.45

2.4

2.2

—

(3020874) Milk IgE Ab [Units/volume] in Serum

654

1.48

3.44

1.3

1.1

15.26

1.32

u/ml

1.36

252

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.77

3.41

1.2

1.3

—

(4034850) Laboratory test

167

1227

1.35

3.41

8.8

7.5

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

428

1.59

3.37

2.5

2.1

5.34

2.78

u/ml

0.49

159

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1058

9368

1.13

3.36

1.9

1.8

1.39

1.37

0.26

946

8530

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.57

3.35

1.2

1.20

1.18

mmol/l

0.26

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2.50

3.34

1.7

1.6

18.29

15.64

nmol/l

—

(3049717) Cytology report of Urine Cyto stain

121

847

1.41

3.32

1.9

2.3

—

(3007566) Smooth muscle Ab [Titer] in Serum

208

1585

1.30

3.31

1.3

1.4

105.29

81.58

titre

0.29

171

(21494755) Public health laboratory ask at order entry panel

753

8388

0.87

3.29

1.3

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

463

1.56

3.26

1.1

1.3

216.36

259.64

titre

0.14

(3011288) Drugs identified in Urine by Screen method Nominal

516

4344

1.18

3.26

3.6

2.8

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

558

1.51

3.25

1.5

1.54

1.29

promille

0.77

451

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

223

1.81

3.24

2.5

2.2

16.31

16.50

umol/l

0.03

223

(3006653) Thiamine [Moles/volume] in Blood

210

1.83

3.18

1.4

1.3

133.87

132.91

nmol/l

0.04

210

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

601

1.48

3.18

1.4

345.08

355.84

pmol/l

0.11

527

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

149

1089

1.35

3.17

1.7

1.6

369.74

366.04

mu/l

0.05

126

910

(3028707) Methadone [Presence] in Urine by Screen method

304

2439

1.24

3.17

3.5

3.0

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

6.27

3.14

1.1

1.4

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

643

1.46

3.14

1.3

1.1

31.66

6.57

u/ml

0.51

204

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

188

1426

1.31

3.11

4.1

4.9

1.69

1.70

0.04

178

1338

(3017354) Segmented neutrophils/Leukocytes in Blood

330

1.65

3.10

3.9

2.5

54.41

56.20

0.28

288

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

227

1.78

3.07

1.9

2.4

128.91

112.14

ng/l

0.57

184

(3007930) Methemoglobin/Hemoglobin.total in Blood

175

1317

1.32

3.07

4.0

5.1

0.84

0.94

1.88

165

1232

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

123

2.08

3.07

1.9

2.5

0.61

mmol/l

0.02

123

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

765

6673

1.15

3.06

3.1

21.92

21.47

0.23

236

2169

(3023410) Appearance of Cerebral spinal fluid

623

1.46

3.05

3.1

1.7

—

(3000330) Specific gravity of Urine by Test strip

230

1797

1.27

3.04

2.7

2.8

1.02

ratio

1.28

200

1563

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

117

2.11

3.03

1.1

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

2.21

3.01

1.1

1.2

0.07

0.40

u/ml

1.31

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

277

3333

0.81

2.98

1.1

0.64

ratio

0.03

279

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

600

5154

1.16

2.97

2.4

0.73

0.66

ug/l

0.32

259

2444

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.29

2.96

1.3

—

(3042733) HLA Ab [Presence] in Serum

173

1.88

2.95

4.4

4.7

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

2.40

2.94

1.8

2.7

1.27

1.20

umol/l

0.36

(3000475) Leukocytes [#/volume] in Synovial fluid

123

884

1.38

2.94

1.5

1.7

6828.40

14978.21

e6/l

2.87

629

(3045683) HLA typing for celiac disease panel - Blood or Tissue

436

1.54

2.93

1.0

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

459

3864

1.18

2.93

1.6

1.7

302.69

311.57

mu/l

0.24

404

3504

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

147

1.95

2.86

1.1

1.2

8.57

4.83

u/ml

0.37

117

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

211

1.78

2.85

2.2

1.8

116.03

184.29

au/ml

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

617

1.44

2.82

1.3

5.36

6.15

umol/l

1.11

551

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

348

1.59

2.78

1.2

60.54

72.98

u/l

0.94

306

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

910

8080

1.13

2.77

2.3

2.2

—

(21494814) CD8 cells/Lymphocytes in Specimen

156

1.90

2.76

1.8

2.4

26.57

28.94

0.56

156

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

221

1.74

2.74

1.1

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

179

1.82

2.68

1.8

1.7

0.11

0.19

nmol/l

1.25

132

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

2.23

2.67

1.2

3.93

11.31

pmol/l

—

(3000093) Morphology [Interpretation] in Blood Narrative

352

1.57

2.66

1.2

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.13

2.66

1.0

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

511

1.47

2.65

1.7

1.8

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

503

1.47

2.65

1.0

1.1

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

145

1.90

2.62

1.1

1.2

8.04

9.36

u/ml

0.06

116

(3041672) Baker's yeast Ab [Presence] in Serum

2.46

2.61

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

968

8657

1.12

2.60

3.8

3.6

1.41

1.78

ug/l

2.14

870

7929

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

386

1.53

2.59

2.0

34.46

23.76

mg/l

0.81

147

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

106

763

1.37

2.56

3.3

3.1

32.83

44.91

mg/l

1.35

653

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

459

1.48

2.55

1.3

1.2

24.40

33.67

nmol/l

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

333

1.57

2.54

3.3

3.4

0.80

0.79

nmol/l

0.04

270

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

264

1.64

2.54

3.1

39.81

44.11

1.25

141

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.61

2.54

1.0

1.1

0.06

0.03

u/ml

0.81

(3005011) Chlamydia sp Ab [Titer] in Serum

2.18

2.53

1.2

1.3

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

404

1.52

2.53

1.2

19.20

66.11

u/ml

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

125

925

1.34

2.53

1.4

—

(3046861) Legionella sp Ag [Presence] in Urine

7.03

2.52

1.0

—

(3016135) IgD [Mass/volume] in Serum

5.37

2.51

1.3

1.2

32.20

56.08

mg/l

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

196

1542

1.26

2.51

1.7

1.8

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

113

2.01

2.50

1.0

1.1

10.02

0.27

u/ml

—

(3019230) Fractional oxyhemoglobin in Venous blood

126

936

1.33

2.49

4.3

4.7

60.97

63.87

0.86

126

929

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

2.82

2.49

22.4

3.5

110.92

102.36

g/l

0.56

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

107

2.03

2.46

2.5

4.0

5.07

4.91

kpa

0.28

107

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

107

2.03

2.46

1.0

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

107

2.03

2.46

2.5

4.0

10.90

10.98

kpa

0.03

107

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

274

1.62

2.46

2.9

2.5

10.12

9.51

mg/l

0.32

232

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

344

1.55

2.45

1.4

1.3

900.00

978.33

titre

0.17

(3020356) Listeria sp identified in Specimen by Organism specific culture

2.38

2.45

1.3

1.2

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

121

1.96

2.44

1.6

1.2

—

(3002079) Sodium [Moles/time] in 24 hour Urine

237

1.67

2.43

1.7

1.3

174.72

171.09

mmol/24h

0.07

237

(3032641) Amino acids panel - Urine

3.75

2.42

1.0

1.2

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

322

1.56

2.41

1.3

1.2

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

2.13

2.41

2.8

3.8

3.72

6.87

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

164

1.80

2.41

1.1

1.3

29.87

12.33

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

300

3498

0.84

2.39

1.1

0.88

0.89

g/l

0.01

300

3493

(3034860) Kappa light chains.free [Mass/volume] in Serum

105

765

1.36

2.37

3.3

3.0

39.20

57.19

mg/l

1.10

654

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

2.51

2.36

5.8

8.2

6.57

5.97

mmol/l

0.18

(3032057) Clostridioides difficile [Presence] in Stool

2.51

2.36

1.5

1.9

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

569

4958

1.14

2.35

2.6

2.2

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

754

6688

1.12

2.35

1.5

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

509

1.44

2.34

1.1

1.2

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

309

1.57

2.34

1.1

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

152

1.82

2.31

2.0

143.87

90.21

ng/l

0.37

152

(3017569) Oxygen content in Arterial blood

138

1.86

2.30

1.3

2.2

17.58

16.54

0.86

138

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1056

9556

1.10

2.28

2.5

2.3

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

288

1.58

2.27

1.4

1.3

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

587

1.40

2.26

1.2

1.1

31.41

39.77

mg/l

2.01

496

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

227

1.65

2.26

2.1

1.8

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.11

2.25

1.1

1.0

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

2.90

2.23

1.2

1.0

—

(3039443) Prostate specific Ag panel - Serum or Plasma

639

1.38

2.22

1.5

1.4

—

(3008536) Aspergillus sp Ab [Presence] in Serum

2.34

2.21

3.6

2.4

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

314

1.54

2.20

1.4

1.6

33.86

37.33

0.31

199

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

516

1.42

2.19

4.5

5.1

24.62

114.70

u/ml

2.31

178

(3020876) Protein [Mass/time] in 24 hour Urine

370

1.49

2.19

2.2

2.4

1.18

1.48

g/24h

0.44

222

(3013466) aPTT in Blood by Coagulation assay

3.06

2.18

1.2

1.1

36.53

37.57

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

292

1.55

2.16

1.2

1.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

270

1.57

2.12

1.2

1.5

5.02

6.44

u/l

1.17

236

(3006598) pH of Arterial cord blood

128

1.85

2.11

1.0

—

(3004959) Base excess in Arterial cord blood by calculation

128

1.85

2.11

1.0

-0.60

-2.23

mmol/l

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

604

1.37

2.10

1.3

1.5

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

263

1.58

2.10

4.1

2.3

24.67

27.79

umol/l

1.95

245

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

150

1.77

2.09

2.0

2.2

1.06

1.88

mmol/l

1.03

112

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

613

1.37

2.09

1.0

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

2.13

2.06

1.0

10.96

2.84

u/ml

—

(3002256) Pathology report gross observation

631

5591

1.12

2.03

1.2

—

(4198724) Urine methamphetamine measurement

583

1.37

2.02

3.2

2.7

—

(44806420) Estimation of glomerular filtration rate

575

1.37

2.02

2.3

2.0

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

501

1.40

2.00

1.8

1.7

—

(40757373) Influenza virus identified in Isolate

2.23

2.00

1.4

1.3

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

678

1.34

1.99

2.7

2.9

2.05

2.73

ratio

0.35

366

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

511

1.39

1.97

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

123

946

1.29

1.96

1.1

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

300

1.51

1.94

1.2

1.1

19.55

33.05

u/ml

0.18

202

(3052592) Norovirus Ag [Presence] in Stool

2.46

1.94

1.4

1.3

—

(3028433) Virus identified in Specimen by Culture

118

1.84

1.92

1.0

1.1

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

223

1.59

1.90

1.1

9.09

14.41

u/ml

—

(4024509) Urine culture

227

1875

1.20

1.90

1.9

1.7

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

3.69

1.90

1.0

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

142

1117

1.26

1.90

1.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

177

1427

1.23

1.90

2.7

2.5

6.32

6.38

umol/l

0.03

126

1072

(3037121) Protein [Mass/volume] in Urine

181

1463

1.22

1.89

4.4

3.7

481.51

496.48

mg/l

0.02

100

726

(3006442) Creatine [Moles/volume] in Serum or Plasma

294

1.51

1.89

1.2

69.16

78.01

umol/l

2.75

294

(40768446) Kidney Pathology biopsy report

208

1.61

1.89

2.3

1.7

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

247

1.56

1.88

1.4

1.2

—

(3036048) Francisella tularensis Ab [Titer] in Serum

126

1.80

1.88

1.0

1.1

—

56.00

—

(3000764) Benzodiazepines [Presence] in Urine

706

6324

1.11

1.88

2.4

2.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

112

1.85

1.87

1.3

1.7

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

112

1.85

1.87

1.3

1.7

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

134

1.77

1.85

4.1

3.5

1.71

1.13

0.39

134

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

127

1.79

1.84

1.0

1.1

0.97

0.91

u/ml

0.02

(3016879) Cocaine [Presence] in Urine

659

5889

1.11

1.84

2.4

2.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

190

1549

1.21

1.84

1.6

0.31

0.44

nmol/l

1.89

153

1268

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

452

1.40

1.82

1.1

1.2

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

3.48

1.81

1.0

1.1

0.09

0.03

u/ml

—

(3028300) Cannabinoids [Presence] in Urine

711

6387

1.11

1.80

2.4

2.1

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

128

1.77

1.80

1.0

1.1

21.62

2.10

u/ml

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

453

1.39

1.80

1.1

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

453

1.39

1.80

1.1

1.2

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.05

1.79

1.1

1.0

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

114

1.82

1.78

1.3

1.7

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

1.91

1.77

1.1

8.14

12.11

u/ml

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

340

1.45

1.76

1.1

9.40

8.19

mm/h

0.26

340

(3027008) Opiates [Presence] in Urine

708

6369

1.11

1.75

2.4

2.0

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

438

3834

1.13

1.75

1.3

1.4

—

(3024471) HLA-A [Type]

159

1.67

1.75

1.0

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

490

1.37

1.73

1.1

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

465

1.38

1.73

1.1

1.2

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

407

1.41

1.73

1.5

1.6

53.50

54.43

0.07

258

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

317

1.46

1.72

1.9

2.4

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.63

1.69

1.0

1.1

—

(3024932) HLA-DR beta [Type]

161

1.65

1.68

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

418

1.39

1.67

1.3

1.2

100.80

118.97

pmol/l

2.05

418

(3010144) Erythrocytes [#/volume] in Synovial fluid

304

1.46

1.65

1.4

26399.81

87480.96

e6/l

1.19

201

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

487

1.36

1.64

1.2

1.1

—

1.34

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

3.11

1.63

1.0

1.2

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

3.11

1.63

1.3

1.0

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

2.54

1.62

1.1

—

(40757494) Bilirubin.total [Moles/volume] in Blood

163

1.63

1.62

7.0

2.5

89.63

69.65

umol/l

—

(3003181) Sodium [Moles/volume] in Urine

565

1.33

1.61

2.5

1.7

71.90

67.36

mmol/l

0.34

450

(3022493) Free Hemoglobin [Mass/volume] in Plasma

226

1.53

1.59

4.7

4.8

84.41

2821.66

mg/l

1.07

151

(3027944) Amphetamines [Presence] in Urine

697

6301

1.10

1.58

2.3

2.0

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

170

0.46

1.57

1.0

1.1

—

(3045142) Bone marrow Pathology biopsy report

374

1.40

1.56

1.8

1.4

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

196

1.56

1.55

1.0

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.81

1.54

1.2

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

1.88

1.52

1.2

1.3

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

605

1.31

1.52

1.1

1.58

1.39

u/ml

0.07

201

(3000034) Microalbumin [Mass/volume] in Urine

261

1.47

1.52

3.2

3.0

61.25

98.69

mg/l

0.48

191

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

103

805

1.26

1.52

1.5

6.45

6.77

mmol/l

0.67

732

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

494

1.34

1.51

1.5

1.7

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

3.28

1.50

1.2

1.0

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

386

1.38

1.48

1.8

3.1

2.95

3.80

nmol/l

0.39

372

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

124

994

1.23

1.47

1.3

3.30

3.68

u/ml

0.08

390

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

255

1.47

1.8

3.75

3.35

mg/l

0.24

247

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

446

1.35

1.46

1.1

1.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

166

1372

1.20

1.45

1.3

—

(21494434) Karyotype in Bone marrow

256

1.46

1.44

1.4

1.2

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

1.97

1.42

3.2

1.6

—

9692.86

—

(3001186) Copper [Moles/volume] in Serum or Plasma

193

1.53

1.42

1.6

1.2

17.06

16.06

umol/l

0.38

167

(3033086) Enterovirus Ab [Titer] in Serum

3.08

1.41

1.0

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

269

2321

1.15

1.39

2.4

2.7

31.70

49.10

u/ml

1.54

256

2250

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

719

1.26

1.38

2.5

110.33

108.69

ug/min

0.01

469

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

572

1.29

1.37

1.1

204.53

239.01

mg/l

1.46

508

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

529

0.71

1.35

3.2

3.7

82.77

29.60

u/ml

0.53

513

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

285

1.42

1.34

1.1

1.3

55.14

73.50

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.16

1.34

1.7

1.6

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

310

1.40

1.34

2.2

39.58

22.43

ug/l

0.39

302

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

542

1.29

1.30

1.0

1.1

—

(3039000) Anion gap in Blood by calculation

673

1.26

1.30

5.3

7.2

10.99

11.33

mmol/l

0.52

600

(3018572) Chloride [Moles/volume] in Blood

674

1.26

1.28

5.3

7.2

104.27

105.37

mmol/l

1.28

601

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.06

1.27

1.1

1.0

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

2.06

1.27

15.7

3.3

33.22

43.91

umol/l

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

199

1.49

1.26

2.1

1.6

0.55

4.53

u/field

2.92

144

(37208534) Antinuclear antibody arbitrary concentration in serum

191

1.50

1.26

1.0

1.1

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

128

1.62

1.26

1.1

2.15

2.40

u/ml

0.05

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

382

1.34

1.25

1.1

1.07

1.06

ratio

0.30

321

(3005033) Fetal Nuchal fold Thickness US

251

2798

0.88

1.24

1.6

1.5

1.25

1.26

0.20

183

2134

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

435

1.32

1.22

1.1

1.2

—

(3007542) Rye IgE Ab [Units/volume] in Serum

1.97

1.22

1.0

0.24

0.21

u/ml

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.97

1.22

7.5

3.0

—

(3044242) Glucose [Moles/volume] in Arterial blood

161

1.53

1.21

1.3

2.4

6.89

8.18

mmol/l

2.11

161

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

122

1.62

1.20

1.1

1.0

0.40

0.45

u/ml

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

2.13

1.19

1.6

2.1

189.81

240.47

ug/l

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

107

1.66

1.19

1.1

—

(3016031) Almond IgE Ab [Units/volume] in Serum

1.71

1.19

1.1

0.19

1.15

u/ml

2.90

(3038071) Oxygen [Partial pressure] in Mixed venous blood

100

1.67

1.17

17.1

5.9

7.53

5.43

kpa

0.79

100

(3007463) Buprenorphine [Presence] in Urine

1.93

1.17

9.1

5.9

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

381

3402

1.11

1.17

1.4

1.3

239.30

223.58

miu/ml

0.37

181

1657

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

211

1.45

1.16

1.1

—

0.13

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

108

1.64

1.15

1.1

1.2

—

(3034891) Synovial lining cells/cells in Synovial fluid

171

1.50

1.15

1.2

1.5

5.38

5.37

—

(3026250) Tacrolimus [Mass/volume] in Blood

228

1.43

1.15

50.2

42.0

7.28

7.44

ug/l

0.22

213

(3019832) Treponema pallidum Ab [Presence] in Serum

1399

13162

1.06

1.13

1.9

—

(3028717) Thiamine [Mass/volume] in Blood

1.75

1.11

1.4

1.2

55.00

65.05

ug/l

3.03

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

673

7086

0.93

1.10

1.5

3.44

3.45

mmol/l

0.10

438

4568

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

2.22

1.09

1.6

1.5

9.53

12.11

pmol/l

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

261

2872

0.89

1.08

1.6

1.5

—

(3040151) Glucose [Moles/volume] in Capillary blood

444

1.29

1.08

2.6

5.2

8.04

6.99

mmol/l

0.70

359

(4146454) Self-monitoring of blood glucose

290

1.36

1.08

2.6

2.9

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

265

1.38

1.07

1.0

1.1

97.93

91.36

0.62

215

(3026926) Nortriptyline [Moles/volume] in Serum or Plasma

2.34

1.07

2.2

1.6

113.80

264.87

nmol/l

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.15

1.06

1.4

1.2

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

137

1152

1.17

1.06

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.09

1.04

1.0

1.1

1.67

1.52

umol/24h

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

192

1.44

1.03

4.8

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

192

1.44

1.03

4.8

1.4

—

(3000012) Reticulocyte production index

396

1.29

1.02

2.1

1.8

0.95

0.90

0.23

241

(3018333) Ribosomal P Ab [Presence] in Serum

431

1.28

1.02

1.1

1.2

—

(1761482) Bacteria [#/volume] in Urine by Culture

705

1.22

1.02

2.8

3.5

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

1.68

1.00

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

286

1.34

0.99

1.7

—

(3016750) Collection duration of Urine

194

1.42

0.99

2.0

2.3

519.18

508.25

min

0.20

154

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

137

1.51

0.99

1.1

1.3

138.59

125.32

nmol/l

0.14

107

(3008295) Osmolality of Serum or Plasma

468

1.26

0.99

1.5

1.8

284.80

285.44

mosm/kgh2o

0.07

358

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

109

907

1.19

0.97

1.1

111.55

115.38

0.78

101

832

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

0.00

0.97

0.0

1.1

—

20.24

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

575

1.24

0.97

1.4

1.3

203.93

212.11

pmol/l

0.14

575

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

313

1.32

0.97

1.1

1.0

8.36

16.12

u/ml

2.74

222

(3013336) Amino acids [Identifier] in Serum or Plasma

1.86

0.97

6.4

2.5

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

109

908

1.18

0.96

2.9

2.7

22.36

26.89

mg/l

0.69

593

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

321

2878

1.10

0.95

1.8

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

5097

49611

1.05

0.95

19.0

13.3

334.17

334.08

g/l

0.28

5078

49284

(4027681) Cerebrospinal fluid IgG ratio and IgG index

471

1.26

0.95

1.3

1.2

0.62

0.68

ratio

0.36

280

(3014271) Vancomycin [Susceptibility]

1.59

0.94

2.6

2.5

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

268

2916

0.90

0.94

1.7

1.6

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

252

2235

1.11

0.93

1.4

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

1.64

0.92

1.0

0.01

0.02

u/ml

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

2.19

0.92

4.5

3.1

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

1.71

0.92

1.9

1.5

—

(3042517) Benzodiazepines panel - Urine

148

1.46

0.91

4.9

3.0

—

(4035726) Immunohistochemistry procedure

333

3003

1.10

0.89

1.4

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

117

989

1.17

0.89

1.9

2.7

0.87

0.76

nmol/l

0.76

100

856

(3039744) RNA polymerase III Ab [Units/volume] in Serum

1.92

0.89

1.0

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

556

1.22

0.88

1.7

4.0

60.59

839.68

u/ml

1.00

507

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

583

1.22

0.88

2.2

2.1

7203.61

344.01

pmol/l

0.46

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

283

2535

1.10

0.88

1.7

3.91

3.97

mg/l

0.05

213

1734

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

112

945

1.17

0.87

1.3

4.57

3.96

u/ml

0.22

448

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

105

882

1.17

0.87

1.4

1.5

—

(3025130) Human papilloma virus identified in Specimen

126

1077

1.15

0.84

1.9

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.66

0.84

2.1

2.6

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.76

0.83

1.7

1.9

—

(4195642) Thrombophilia screening test

106

896

1.17

0.82

1.1

1.2

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

678

1.19

0.82

1.1

—

2.65

—

(4094501) Cardiovascular stress test using bicycle ergometer

112

954

1.16

0.80

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

877

9044

0.95

0.80

1.7

3.55

3.54

ratio

0.10

640

6542

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

0.50

0.77

2.8

1.7

39.16

41.08

g/l

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

256

2301

1.10

0.77

1.3

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

137

1190

1.14

0.75

1.2

—

(3043410) Blood group antigens tested for on Red Blood Cells

122

1.45

0.75

1.3

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

481

0.80

0.70

7.0

6.4

8.31

8.90

0.39

481

(40761995) Spermatozoa Progressive [#/volume] in Semen

481

0.80

0.70

3.5

3.2

49.05

44.04

0.93

481

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

323

1.25

0.68

1.4

1.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

439

1.21

0.68

1.3

1.2

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

327

2994

1.08

0.67

1.5

1.4

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

119

1035

1.13

0.67

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

421

4408

0.94

0.66

1.5

1.4

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

263

1.27

0.66

8.0

8.3

11.10

14.25

ug/l

0.19

190

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

513

1.19

0.66

1.1

278.14

279.99

mg/l

0.07

477

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

255

1.28

0.65

3.4

1.8

1.00

1.51

u/field

0.88

141

(3004775) Volume in Urine collected for unspecified duration

238

1.28

0.64

2.1

2.3

775.22

628.79

0.86

173

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

826

1.15

0.64

1.5

1.3

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.57

0.64

1.0

1.1

—

(3035880) pH of Pleural fluid

103

1.43

0.60

1.0

1.3

7.43

7.37

—

(3037756) Immunofixation for Serum or Plasma

500

1.18

0.60

1.5

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.60

0.0

1.2

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

1.64

0.60

8.2

10.8

356.60

117.68

e6/l

—

(4038314) Semen analysis, post vasectomy

146

1.35

0.58

1.2

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.53

0.58

1.1

1.0

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.53

0.58

1.1

1.0

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

321

3370

0.93

0.57

1.6

1.5

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.69

0.57

3.3

2.3

0.67

0.83

u/field

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1096

0.89

0.55

3.0

4.0

1320.13

1464.44

u/ml

0.04

961

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.60

0.54

1.3

1.1

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

773

1.14

0.54

1.1

1.40

1.47

g/l

1.15

715

(3027923) C peptide [Moles/volume] in Serum or Plasma

236

1.25

0.54

1.8

2.0

1.53

1.30

nmol/l

0.62

186

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

347

3623

0.94

0.53

1.6

1.5

68.35

61.57

ug/l

0.51

297

3101

(3044927) Protein electrophoresis panel - Urine

210

1.27

0.53

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.52

0.52

1.2

1.5

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

330

3440

0.94

0.50

1.6

1.5

1.22

1.16

ratio

0.47

202

2079

(3020650) Glucose [Presence] in Urine

198

0.75

0.49

1.5

0.00

0.05

estimate

1.06

198

(4268621) Lupus anticoagulant assay

706

1.13

0.49

2.3

2.4

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.53

0.48

1.1

1.0

—

(3041806) Other cells [#/volume] in Blood by Manual count

679

1.13

0.48

1.6

1.4

0.52

e9/l

0.02

679

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

272

2516

1.07

0.47

1.5

58.47

60.61

ug/l

0.38

272

2516

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

126

1.33

0.47

1.1

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

109

1.36

0.47

1.0

1.1

6.53

6.26

u/ml

0.03

109

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

332

3451

0.94

0.46

1.6

1.5

0.95

ratio

0.07

204

2090

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

332

3451

0.94

0.46

1.6

1.5

1.16

1.20

ratio

0.36

209

2101

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

296

2749

1.06

0.46

3.2

4.3

9.19

35.48

ug/l

1.19

213

2091

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.41

0.45

1.0

1.1

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

1.41

0.45

1.1

1.2

—

(4281824) Cell count and differential, peritoneal fluid

368

0.83

0.45

1.2

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

119

1.32

0.44

1.1

1.0

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

1.45

0.44

1.6

1.8

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

196

1799

1.07

0.44

1.3

3.78

4.06

ug/l

0.22

185

1699

(1761868) Lipid panel - Serum or Plasma

2442

23671

1.02

0.43

2.5

2.4

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

160

0.74

0.43

1.0

75.69

38.14

ng/l

—

113

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

208

1.23

0.43

1.2

1.1

22.86

160.41

ng/l

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

120

1.31

0.42

1.1

1.3

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

330

3086

1.06

0.42

1.6

—

(40768800) Prostate Pathology biopsy report

317

1.18

0.42

1.2

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.54

0.41

1.2

1.1

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

159

0.74

0.41

1.0

518.14

290.22

ng/l

—

116

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.41

0.0

1.0

—

(3020491) Glucose [Moles/volume] in Blood

364

0.84

0.41

1.3

1.6

6.59

5.90

mmol/l

0.61

274

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.49

0.41

1.0

1.2

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.33

0.40

1.5

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.39

0.40

1.5

1.2

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

265

1.19

0.39

1.1

—

(3009677) Dengue virus Ab [Presence] in Serum

1.41

0.38

1.0

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

185

1.22

0.37

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

194

1.22

0.37

1.1

1.0

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

123

1.28

0.36

1.1

1.0

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

123

1.28

0.36

3.7

3.4

1.93

2.12

ratio

0.23

113

(3034426) Prothrombin time (PT)

186

1.22

0.36

1.6

1.2

27.35

28.95

0.84

186

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.35

0.35

1.7

1.3

5.62

5.44

mmol/l

0.40

(43055514) Macroprolactin [Presence] in Serum or Plasma

287

1.17

0.35

1.3

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

325

0.85

0.34

1.5

1.8

—

(3033099) Centromere Ab [Titer] in Serum

1.31

0.34

1.0

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

1.28

0.32

1.2

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

144

1.23

0.31

1.6

1.5

9.10

8.98

ug/l

0.04

144

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

110

1005

1.08

0.31

1.2

1.1

114.74

2108.45

iu/ml

0.93

234

(3002619) Bacteria identified in Specimen by Culture

109

1.26

0.30

1.1

1.2

—

(44806071) Cardiolipin IgM antibody measurement

1.33

0.29

1.1

1.0

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

1.23

0.29

1.0

1.1

—

(3000919) Neutrophils/Leukocytes in Pleural fluid

1.25

0.27

1.1

1.3

33.38

30.28

—

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

102

1.25

0.27

1.2

1.4

54.38

37.46

—

(3010937) Rubella virus Ab [Presence] in Serum

0.69

0.26

1.0

1.1

—

(3004451) EKG impression Narrative

157

1.19

0.26

1.3

1.2

—

(40768793) Breast Pathology biopsy report

107

987

1.07

0.26

1.3

—

(3017509) Phencyclidine [Presence] in Urine

130

1.21

0.25

1.5

1.9

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.27

0.25

1.0

1.1

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.23

0.25

1.2

1.1

—

(3024263) Appearance of Synovial fluid

176

1.17

0.25

1.4

2.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

353

1.12

0.24

2.4

2.0

28.23

24.91

mg/l

0.16

237

(40758292) HTLV I+II Ab panel - Serum

135

0.80

0.24

1.1

1.3

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

723

1.08

0.24

3.1

3.8

6.76

46.75

u/ml

1.07

716

(3016273) Islet cell 512 Ab [Units/volume] in Serum

0.70

0.24

1.0

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

392

1.11

0.23

1.0

1.1

1.27

1.05

u/l

0.31

161

(4211845) Urine protein measurement

224

1.14

0.23

2.6

2.2

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

224

1.14

0.23

1.3

1.5

70151.25

85834.40

e6/l

0.13

116

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.30

0.23

1.8

1.5

423.70

578.81

nmol/l

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.23

0.22

1.4

1.5

—

(40768441) Liver Pathology biopsy report

366

1.10

0.21

1.4

1.5

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.21

0.0

1.0

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.1

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.21

0.0

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.21

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.21

0.0

2.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.21

0.0

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.21

0.0

1.0

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.17

0.21

1.0

1.1

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.20

0.0

1.0

—

2.77

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.23

0.20

7.1

4.1

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

116

1086

1.05

0.19

1.6

1.4

61.63

120.26

pmol/l

2.29

111

1057

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

607

1.07

0.19

1.5

7.15

7.63

mmol/l

0.59

592

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

297

0.89

0.19

2.0

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.16

0.19

1.0

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

172

0.86

0.18

1.2

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

145

1.15

0.17

2.1

2.4

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

860

1.05

0.17

1.7

2.4

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

0.72

0.17

1.8

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

345

1.08

0.15

2.7

2.3

184.18

149.35

nmol/l

0.49

307

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

0.80

0.14

5.9

3.5

3.29

33.60

ug/l

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

202

2045

0.97

0.14

1.3

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

270

0.91

0.14

1.3

64.28

68.01

ug/l

0.15

270

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

310

0.92

0.13

1.3

1.5

4.91

5.32

mmol/l

1.81

299

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

102

1.16

0.13

1.7

1.3

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

102

1.16

0.13

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

102

1.16

0.13

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

102

1.16

0.13

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

102

1.16

0.13

1.0

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

899

1.04

0.12

1.2

—

(3044007) Cell count panel - Peritoneal fluid

1.17

0.12

2.1

2.2

—

(40768795) Lymph node Pathology biopsy report

409

1.06

0.11

1.3

1.2

—

(3022670) pH of Venous cord blood

1.14

0.10

1.0

1.1

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.14

0.10

2.6

1.6

365.40

317.44

umol/24h

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.14

0.10

1.2

1.0

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

143

0.89

0.09

1.0

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

142

0.90

0.08

2.7

2.5

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

1.04

0.08

1.0

175.50

165.05

g/l

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

0.81

0.08

1.2

2.7

133.80

1403.27

u/l

—

(3023199) Leukocytes [#/volume] in Pleural fluid

259

1.06

0.08

1.4

4574.81

2693.49

e6/l

0.40

167

(40765089) Chromosome analysis panel - Blood by G-banded

542

0.96

0.07

1.0

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

116

1.10

0.07

1.1

1.0

—

(3047189) Immunofixation for 24 hour Urine

110

0.89

0.07

1.9

1.5

—

(1617658) Protocol used for examination of sentinel lymph nodes

251

1.06

0.07

1.0

1.1

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

120

0.90

0.07

1.1

1.18

1.26

mom

0.14

120

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.12

0.06

1.0

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

135

1310

1.01

0.04

1.4

1.5

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

676

6620

1.01

0.04

1.6

1053.99

1012.98

mu/l

0.47

578

5785

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

109

1.08

0.04

1.1

1.0

—

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

168

1.05

0.03

1.5

1.8

—

159.00

—

(3001556) Androgen free Index in Serum or Plasma

126

0.94

0.02

2.3

1.2

—

(21494890) Protein electrophoresis panel - 24 hour Urine

240

1.03

0.00

1.6

2.0

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

138

1.00

0.00

1.0

1.1

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

1.05

0.00

8.2

4.3

25.50

24.60

mg/l

—

(3017704) Immunofixation for Urine

130

0.98

0.00

1.2

1.6

—

(3029396) Erythrocyte agglutination [Presence] in Blood

359

0.99

0.00

4.7

3.2

—

(3006462) Nitrate [Presence] in Urine

205

1.01

0.00

2.8

2.2

—

(40765096) Chromosome analysis panel by Banding

107

1.01

0.00

1.4

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

438

1.01

0.00

1.0

1.1

1195.36

1485.33

miu/ml

1.24

438

(3023487) Leukocytes [#/volume] in Peritoneal fluid

101

0.97

0.00

2.1

2.5

125.40

925.22

e6/l

—

(3001019) Free T4 and TSH panel - Serum or Plasma

384

3783

1.00

0.00

1.5

1.6

—

(40768806) Pleura Pathology biopsy report

217

1.00

0.00

1.5

1.6

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

134

1.03

0.00

1.4

1.1

—

(3045788) Cell count panel - Pleural fluid

220

0.98

0.00

1.3

1.5

—

(4133840) Spirometry

174

1.02

0.00

1.1

—

(3012441) Differential panel - Pleural fluid

225

1.01

0.00

1.4

1.5

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

0.00

0.0

1.2

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

0.93

0.00

2.0

1.6

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

0.00

-0.00

0.0

1.2

—

1.33

—

(37021550) Renin [Units/volume] in Plasma --upright

0.97

-0.00

1.1

1.5

277.43

59.79

mu/l

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

0.00

-0.00

0.0

1.8

—

(3027859) Formaldehyde IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.98

-0.00

1.1

1.5

—

(3002853) Influenza virus B Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.92

-0.00

1.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

-0.00

0.0

1.4

—

(3004768) Phthalic anhydride IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

0.89

-0.00

3.6

7.9

12.54

10.94

—

(3004282) Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.8

—

10.38

—

(3044009) aPTT.lupus sensitive (LA screen)

0.86

-0.00

1.0

1.2

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

-0.00

0.0

1.6

—

5.44

—

(3008896) Cortisol [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

50.00

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.1

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

2.4

—

0.02

—

(3008343) Lysozyme [Mass/volume] in Urine

0.00

-0.00

0.0

1.0

—

0.42

—

(3004560) Lymphocytes [#/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3033463) Neutrophils [#/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.1

—

3325.00

—

(36303858) Crystals [Presence] in Urine

0.00

-0.00

0.0

1.1

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.2

—

2.42

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

0.00

-0.00

0.0

3.6

—

(3034092) Cytoplasmic Ig cells/cells in Blood

0.94

-0.00

4.6

5.4

0.18

0.22

—

(3004541) Aldosterone [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

42.40

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.02

—

Mortality – FinRegistry

↥

Association

Association between endpoint J10_LARYNGITIS and mortality.

Females

Parameter	HR [95% CI]	p-value
J10_LARYNGITIS	1.413 [1.2, 1.67]	< 0.001
Birth year	0.993 [0.98, 1.0]	0.13

During the follow-up period (1.1.1998 — 31.12.2019), 969 out of 30916 females with J10_LARYNGITIS died.

Males

Parameter	HR [95% CI]	p-value
J10_LARYNGITIS	1.41 [1.07, 1.87]	0.016
Birth year	0.989 [0.98, 1.0]	0.015

During the follow-up period (1.1.1998 — 31.12.2019), 775 out of 49448 males with J10_LARYNGITIS died.

Mortality risk

Mortality risk for people of age

years, who have J10_LARYNGITIS.

N-year risk	Females	Males
1	0.139%	0.318%
5	0.796%	1.811%
10	1.901%	4.347%
15	3.684%	8.009%
20	6.57%	13.725%

Relationships between endpoints

↥

Index endpoint: J10_LARYNGITIS – Acute laryngitis and tracheitis

GWS hits: 3

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Acute laryngitis and tracheitis

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints